PURE STORAGE, INC., 10-K filed on 4/3/2023
Annual Report
v3.23.1
Cover - USD ($)
$ in Billions
12 Months Ended
Feb. 05, 2023
Mar. 24, 2023
Aug. 05, 2022
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Feb. 05, 2023    
Current Fiscal Year End Date --02-05    
Document Transition Report false    
Entity File Number 001-37570    
Entity Registrant Name Pure Storage, Inc.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 27-1069557    
Entity Address, Address Line One 650 Castro Street    
Entity Address, Address Line Two Suite 400    
Entity Address, City or Town Mountain View    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 94041    
City Area Code 800    
Local Phone Number 379-7873    
Title of 12(b) Security Class A Common Stock, par value $0.0001 per share    
Trading Symbol PSTG    
Security Exchange Name NYSE    
Entity Well-Known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Entity Shell Company false    
Entity Public Float     $ 8.3
Entity Common Stock, Shares Outstanding (in shares)   308,045,301  
Documents Incorporated by Reference Portions of the registrant’s proxy statement for its 2023 Annual Meeting of Stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. Such proxy statement will be filed with the Securities and Exchange Commission within 120 days of the registrant’s fiscal year ended February 5, 2023.    
Amendment Flag false    
Document Fiscal Year Focus 2023    
Document Fiscal Period Focus FY    
Entity Central Index Key 0001474432    
v3.23.1
Audit Information
12 Months Ended
Feb. 05, 2023
Audit Information [Abstract]  
Auditor Name Deloitte & Touche LLP
Auditor Location San Jose, CA
Auditor Firm ID 34
v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Feb. 05, 2023
Feb. 06, 2022
Current assets:    
Cash and cash equivalents $ 580,854 $ 466,199
Marketable securities 1,001,352 947,073
Accounts receivable, net of allowance of $945 and $1,057 612,491 542,144
Inventory 50,152 38,942
Deferred commissions, current 68,617 81,589
Prepaid expenses and other current assets 161,391 116,232
Total current assets 2,474,857 2,192,179
Property and equipment, net 272,445 195,282
Operating lease right-of-use assets 158,912 111,763
Deferred commissions, non-current 177,239 164,718
Intangible assets, net 49,222 62,646
Goodwill 361,427 358,736
Restricted cash 10,544 10,544
Other assets, non-current 38,814 39,447
Total assets 3,543,460 3,135,315
Current liabilities:    
Accounts payable 67,121 70,704
Accrued compensation and benefits 232,636 205,431
Accrued expenses and other liabilities 123,749 78,511
Operating lease liabilities, current 33,707 35,098
Deferred revenue, current 718,149 562,576
Debt, current 574,506 0
Total current liabilities 1,749,868 952,320
Long-term debt 0 786,779
Operating lease liabilities, non-current 142,473 93,479
Deferred revenue, non-current 667,501 517,296
Other liabilities, non-current 42,385 31,105
Total liabilities 2,602,227 2,380,979
Commitments and contingencies (Note 8)
Stockholders’ equity:    
Preferred stock, par value of $0.0001 per share— 20,000 shares authorized; no shares issued and outstanding 0 0
Class A and Class B common stock, par value of $0.0001 per share— 2,250,000 (Class A 2,000,000, Class B 250,000) shares authorized; 292,633 and 304,076 Class A shares issued and outstanding 30 29
Additional paid-in capital 2,493,769 2,470,943
Accumulated other comprehensive loss (15,504) (8,365)
Accumulated deficit (1,537,062) (1,708,271)
Total stockholders’ equity 941,233 754,336
Total liabilities and stockholders’ equity $ 3,543,460 $ 3,135,315
v3.23.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Feb. 05, 2023
Feb. 06, 2022
Accounts receivable, allowance $ 1,057 $ 945
Preferred stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Preferred stock, shares authorized (in shares) 20,000,000 20,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, shares authorized (in shares) 2,250,000,000 2,250,000,000
Class A common stock    
Common stock, shares authorized (in shares) 2,000,000,000 2,000,000,000
Common stock, par value per share (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares issued (in shares) 304,076,234 292,633,000
Common stock, shares outstanding (in shares) 304,076,234 292,633,000
Class B common stock    
Common stock, shares authorized (in shares) 250,000,000 250,000,000
Common stock, par value per share (in dollars per share) $ 0.0001 $ 0.0001
v3.23.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Feb. 05, 2023
Feb. 06, 2022
Jan. 31, 2021
Revenue $ 2,753,434 $ 2,180,848 $ 1,684,179
Cost of revenue 855,788 708,329 535,255
Gross profit 1,897,646 1,472,519 1,148,924
Operating expenses:      
Research and development 692,528 581,935 480,467
Sales and marketing 883,609 799,001 716,014
General and administrative 237,996 189,981 182,477
Restructuring and other 0 0 30,999
Total operating expenses 1,814,133 1,570,917 1,409,957
Income (loss) from operations 83,513 (98,398) (261,033)
Other income (expense), net 8,295 (30,098) (9,127)
Income (loss) before provision for income taxes 91,808 (128,496) (270,160)
Provision for income taxes 18,737 14,763 11,916
Net income (loss) $ 73,071 $ (143,259) $ (282,076)
Net income (loss) per share attributable to common stockholders, basic (in dollars per share) $ 0.24 $ (0.50) $ (1.05)
Net income (loss) per share attributable to common stockholders, diluted (in dollars per share) $ 0.23 $ (0.50) $ (1.05)
Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, basic (in shares) 299,478 285,882 267,824
Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, diluted (in shares) 339,184 285,882 267,824
Product      
Revenue $ 1,792,153 $ 1,442,338 $ 1,144,098
Cost of revenue 569,793 477,899 352,987
Subscription services      
Revenue 961,281 738,510 540,081
Cost of revenue $ 285,995 $ 230,430 $ 182,268
v3.23.1
Consolidated Statements of Comprehensive Income (Loss) - USD ($)
$ in Thousands
12 Months Ended
Feb. 05, 2023
Feb. 06, 2022
Jan. 31, 2021
Statement of Comprehensive Income [Abstract]      
Net income (loss) $ 73,071 $ (143,259) $ (282,076)
Other comprehensive income (loss), net of tax:      
Unrealized net gains (losses) on available-for-sale securities (7,108) (15,107) 3,213
Reclassification adjustment for net gains on available-for-sale securities included in net income (loss) (31) (668) (1,252)
Change in unrealized net gains (losses) on available-for-sale securities (7,139) (15,775) 1,961
Comprehensive income (loss) $ 65,932 $ (159,034) $ (280,115)
v3.23.1
Consolidated Statements of Stockholders’ Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative-effect adjustment from adoption of ASU 2020-06
Restricted Stock Units
Restricted Stock
Common Stock
Common Stock
Restricted Stock Units
Common Stock
Restricted Stock
Additional Paid-In Capital
Additional Paid-In Capital
Cumulative-effect adjustment from adoption of ASU 2020-06
Additional Paid-In Capital
Restricted Stock Units
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Accumulated Deficit
Cumulative-effect adjustment from adoption of ASU 2020-06
Beginning balance (in shares) at Feb. 02, 2020         264,008                
Beginning balance at Feb. 02, 2020 $ 830,118       $ 26     $ 2,107,579     $ 5,449 $ (1,282,936)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Issuance of common stock upon exercise of stock options (in shares)         9,734                
Issuance of common stock upon exercise of stock options 59,510       $ 1     59,509          
Stock-based compensation expense 242,685             242,685          
Vesting of restricted stock units (in shares)           11,241              
Vesting of restricted stock units     $ 0     $ 1       $ (1)      
Cancellation and forfeiture of restricted stock (in shares)             (317)            
Cancellation and forfeiture of restricted stock       $ 0                  
Tax withholding on vesting of equity awards (in shares)         (490)                
Tax withholding on vesting of equity awards (8,258)             (8,258)          
Common stock issued under employee stock purchase plan (in shares)         3,714                
Common stock issued under employee stock purchase plan 32,439             32,439          
Repurchase of common stock (in shares)         (9,527)                
Repurchases of common stock (135,175)             (135,175)          
Equity awards assumed in an acquisition 8,802             8,802          
Other comprehensive income (loss) 1,961                   1,961    
Net income (loss) (282,076)                     (282,076)  
Ending balance (in shares) at Jan. 31, 2021         278,363                
Ending balance at Jan. 31, 2021 750,006       $ 28     2,307,580     7,410 (1,565,012)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Issuance of common stock upon exercise of stock options (in shares)         5,955                
Issuance of common stock upon exercise of stock options 48,543             48,543          
Stock-based compensation expense 289,185             289,185          
Vesting of restricted stock units (in shares)           12,955              
Vesting of restricted stock units     0     $ 1       (1)      
Cancellation and forfeiture of restricted stock (in shares)             (62)            
Cancellation and forfeiture of restricted stock       $ 0                  
Tax withholding on vesting of equity awards (in shares)         (454)                
Tax withholding on vesting of equity awards (10,835)             (10,835)          
Common stock issued under employee stock purchase plan (in shares)         4,365                
Common stock issued under employee stock purchase plan 36,641             36,641          
Repurchase of common stock (in shares)         (8,489)                
Repurchases of common stock (200,170)             (200,170)          
Other comprehensive income (loss) (15,775)                   (15,775)    
Net income (loss) (143,259)                     (143,259)  
Ending balance (in shares) at Feb. 06, 2022         292,633                
Ending balance at Feb. 06, 2022 $ 754,336 $ (35,127)     $ 29     2,470,943 $ (133,265)   (8,365) (1,708,271) $ 98,138
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2020-06 [Member]                        
Issuance of common stock upon exercise of stock options (in shares)         2,988                
Issuance of common stock upon exercise of stock options $ 25,073             25,073          
Stock-based compensation expense 329,723             329,723          
Vesting of restricted stock units (in shares)           13,916              
Vesting of restricted stock units     $ 0     $ 1       $ (1)      
Tax withholding on vesting of equity awards (in shares)         (643)                
Tax withholding on vesting of equity awards (19,601)             (19,601)          
Common stock issued under employee stock purchase plan (in shares)         3,014                
Common stock issued under employee stock purchase plan 39,966             39,965          
Repurchase of common stock (in shares)         (7,832)                
Repurchases of common stock (219,069)             (219,068)          
Other comprehensive income (loss) (7,139)                   (7,139)    
Net income (loss) 73,071                     73,071  
Ending balance (in shares) at Feb. 05, 2023         304,076                
Ending balance at Feb. 05, 2023 $ 941,233       $ 30     $ 2,493,769     $ (15,504) $ (1,537,062)  
v3.23.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Feb. 05, 2023
Feb. 06, 2022
Jan. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES      
Net income (loss) $ 73,071 $ (143,259) $ (282,076)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Depreciation and amortization 100,432 83,151 70,042
Amortization of debt discount and debt issuance costs 3,210 31,577 29,070
Stock-based compensation expense 327,617 286,963 242,344
Impairment of long-lived assets 0 471 7,505
Other 4,145 13,075 7,340
Changes in operating assets and liabilities, net of effects of acquisitions:      
Accounts receivable, net (70,724) (81,247) 410
Inventory (10,619) 4,118 (8,690)
Deferred commissions 451 (58,383) (48,721)
Prepaid expenses and other assets (31,580) (25,788) (33,982)
Operating lease right-of-use assets 33,813 29,952 28,804
Accounts payable (7,075) 6,711 (14,364)
Accrued compensation and other liabilities 72,084 58,961 76,972
Operating lease liabilities (33,359) (32,351) (27,318)
Deferred revenue 305,768 236,176 140,305
Net cash provided by operating activities 767,234 410,127 187,641
CASH FLOWS FROM INVESTING ACTIVITIES      
Purchases of property and equipment (158,139) (102,287) (94,975)
Acquisitions, net of cash acquired (1,989) 0 (339,641)
Purchases of marketable securities (501,435) (617,043) (573,959)
Sales of marketable securities 6,155 200,482 171,530
Maturities of marketable securities 433,995 366,165 423,936
Other 0 (600) (5,000)
Net cash used in investing activities (221,413) (153,283) (418,109)
CASH FLOWS FROM FINANCING ACTIVITIES      
Net proceeds from exercise of stock options 24,778 48,709 59,339
Proceeds from issuance of common stock under employee stock purchase plan 39,965 36,641 32,439
Proceeds from borrowings, net of issuance costs 0 0 251,892
Principal payments on borrowings and finance lease obligations (257,240) (2,137) 0
Tax withholding on vesting of equity awards (19,601) (10,835) (8,258)
Repurchases of common stock (219,068) (200,170) (135,175)
Net cash provided by (used in) financing activities (431,166) (127,792) 200,237
Net increase (decrease) in cash, cash equivalents and restricted cash 114,655 129,052 (30,231)
Cash, cash equivalents and restricted cash, beginning of year 476,743 347,691 377,922
Cash, cash equivalents and restricted cash, end of year 591,398 476,743 347,691
CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT END OF YEAR      
Cash and cash equivalents 466,199 337,147  
Restricted cash 10,544 10,544 10,544
Cash, cash equivalents and restricted cash, end of year 591,398 476,743 347,691
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION      
Cash paid for interest 1,185 5,019 2,279
Cash paid for income taxes 14,391 12,662 10,522
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING INFORMATION      
Property and equipment purchased but not yet paid 14,902 7,441 10,979
Fair value of equity awards assumed in an acquisition $ 0 $ 0 $ 8,802
v3.23.1
Business Overview
12 Months Ended
Feb. 05, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Business Overview Business Overview
Organization and Description of Business
Pure Storage, Inc. (the Company, we, us, or other similar pronouns) was originally incorporated in the state of Delaware in October 2009 under the name OS76, Inc. In January 2010, we changed our name to Pure Storage, Inc. We are headquartered in Mountain View, California and have wholly owned subsidiaries throughout the world.
v3.23.1
Basis of Presentation and Summary of Significant Accounting Policies
12 Months Ended
Feb. 05, 2023
Accounting Policies [Abstract]  
Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation and Summary of Significant Accounting Policies
Basis of Presentation and Principles of Consolidation
We operate using a 52/53 week fiscal year ending on the first Sunday after January 30. Fiscal 2021 and 2023 were both 52-week years that ended on January 31, 2021 and February 5, 2023, respectively. Fiscal 2022 was a 53-week year that ended on February 6, 2022. Unless otherwise stated, all dates refer to our fiscal years.
The consolidated financial statements include the accounts of the Company and our wholly owned subsidiaries and have been prepared in conformity with accounting principles generally accepted in the United States (U.S. GAAP). All intercompany balances and transactions have been eliminated in consolidation.
Foreign Currency
The functional currency of our foreign subsidiaries is the U.S. dollar. Transactions denominated in currencies other than the functional currency are remeasured to the functional currency at the average exchange rate in effect during the period. At the end of each reporting period, monetary assets and liabilities are remeasured using exchange rates in effect at the balance sheet date. Non-monetary assets and liabilities are remeasured at historical exchange rates. Foreign currency transaction gains and losses are recorded in other income (expense), net in the consolidated statements of operations.
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and accompanying notes. Actual results could differ from these estimates and assumptions due to risks and uncertainties. Such estimates include, but are not limited to, the determination of standalone selling price for revenue arrangements with multiple performance obligations when the price at which the performance obligation sold separately or observable past transactions are not available, useful lives of intangible assets and property and equipment, the period of benefit for deferred contract costs for commissions, stock-based compensation, provision for income taxes including related reserves, fair value of equity assumed, intangible and tangible assets acquired and liabilities assumed for business combinations. Management bases its estimates on historical experience and on various other assumptions which management believes to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.
Concentration Risk
Financial instruments that are exposed to concentration of credit risk consist primarily of cash and cash equivalents, marketable securities, and accounts receivable. At the end of fiscal 2022 and 2023, the majority of our cash and cash equivalents are primarily invested with two global financial institutions and our deposits exceed federally insured limits. These two global financial institutions were identified by the Financial Stability Board in 2022 as being global systemically important banks and are allocated to buckets 2 or higher. Our investments are intended to facilitate liquidity and capital preservation and consist predominantly of highly-rated fixed income securities. Our investment policy also requires diversification of investment type and credit exposures, and includes certain limits on portfolio duration. Management believes that the financial institutions that hold our cash, cash equivalents and marketable securities are financially sound and, accordingly, are subject to minimal credit risk.
We define a customer as an entity that purchases our products and services from one of our channel partners or from us directly. A substantial amount of our revenue and accounts receivable are derived from the United States across a multitude of industries. We perform ongoing evaluations to determine partner and customer credit.
One channel partner represented 10 percent or more of total accounts receivable at the end of fiscal 2022. No customer or channel partner represented 10 percent or more of total accounts receivable at the end of fiscal 2023 or more than 10 percent of revenue for fiscal 2021, 2022 or 2023.
We rely on a limited number of contract manufacturers and suppliers of components for our products. In instances where contract manufacturers and suppliers fail to perform their obligations, we may be unable to find alternative contract manufacturers and suppliers or satisfactorily deliver our products to our customers on time.
Cash and Cash Equivalents
Cash and cash equivalents consist of cash in banks and highly liquid investments, primarily money market accounts and U.S. government treasury notes, purchased with an original maturity of three months or less.
Marketable Securities
We classify our marketable securities as available-for-sale (AFS) at the time of purchase and reevaluate such classification at each balance sheet date. We may sell these securities at any time for use in current operations even if they have not yet reached maturity. As a result, we classify our securities, including those with maturities beyond twelve months, as current assets in the consolidated balance sheets. We carry these securities at estimated fair value and record unrealized gains and losses in accumulated other comprehensive income (loss), which is reflected as a component of stockholders' equity. We evaluate our AFS debt securities with an unamortized cost basis in excess of estimated fair value to determine what amount of that difference, if any, is caused by expected credit losses. Credit-related impairment losses, not to exceed the amount that fair value is less than the amortized cost basis, are recognized through an allowance for credit losses with changes in the allowance for credit losses recognized as a charge to other income (expense), net, in the consolidated statements of operations. Any remaining impairment is included in accumulated other comprehensive income (loss) as a component of stockholders' equity. Realized gains and losses from the sale of marketable securities are determined based on the specific identification method. Realized gains and losses are reported in other income (expense), net in the consolidated statements of operations.
Fair Value of Financial Instruments
The carrying value of our financial instruments, including cash equivalents, accounts receivable, accounts payable and accrued liabilities, approximates fair value.
Accounts Receivable and Allowance
Accounts receivable are recorded at the invoiced amount, and stated at realizable value, net of an allowance for doubtful accounts. Credit is extended to partners and customers based on an evaluation of their financial condition and other factors. We generally do not require collateral or other security to support accounts receivable. We perform ongoing credit evaluations and maintain an allowance for doubtful accounts.
We assess the collectability of the accounts by taking into consideration the aging of our trade receivables, historical experience, and management judgment. We write off trade receivables against the allowance when management determines a balance is uncollectible and no longer actively pursues collection of the receivable.
The following table presents the changes in the allowance for doubtful accounts:
 Fiscal Year Ended
 202120222023
 (in thousands) 
Allowance for doubtful accounts, beginning balance$542 $1,033 $945 
Provision, net of cash received496 (18)377 
Write-offs(5)(70)(265)
Allowance for doubtful accounts, ending balance$1,033 $945 $1,057 
Restricted Cash
Restricted cash is comprised of cash collateral for letters of credit related to our leases and for a vendor credit card program. At the end of fiscal 2022 and 2023, we had restricted cash of $10.5 million.
Inventory
Inventory consists of finished goods and component parts, which are purchased from contract manufacturers. Product demonstration units, which we regularly sell, are the primary component of our inventories. Inventories are stated at the lower of cost or net realizable value. Cost is determined using the specific identification method for finished goods and weighted-average method for component parts. We account for excess and obsolete inventory by reducing the carrying value to the estimated net realizable value of the inventory based upon management’s assumptions about future demand and market conditions. In addition, we record a liability for firm, non-cancelable and unconditional purchase commitments with contract manufacturers and suppliers for quantities in excess of future demand forecasts consistent with excess and obsolete inventory valuations. Inventory write-offs were insignificant for fiscal 2021, 2022 and 2023.
Property and Equipment, Net
Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation and amortization is computed using the straight-line method over the estimated useful lives of the respective assets (test equipment—4 years, computer equipment and software—4 to 5 years, furniture and fixtures—7 years). Leasehold improvements are amortized over the shorter of their estimated useful lives or the remaining lease term. Depreciation commences once the asset is placed in service.
In accordance with our accounting practices, we review the estimated useful lives of our property and equipment on an ongoing basis. In the first quarter of fiscal 2021, management determined that the estimated useful lives of its test equipment and certain computer equipment and software required revision. The estimated useful lives of test equipment and certain computer equipment and software were revised to 4 years. Previously, the estimated useful lives of these assets ranged from 2 to 3 years. The change in estimated useful lives was accounted for as a change in estimate and recognized on a prospective basis effective February 3, 2020. The effect of this change in estimate resulted in a reduction to depreciation expense of $23.6 million during fiscal 2021.
Business Combinations
We allocate the purchase price to the assets acquired and liabilities assumed based on their estimated fair values. The excess of the purchase price over the fair values of the assets acquired and liabilities assumed is recorded as goodwill. During the measurement period, which may be up to one year from the acquisition date, we may record adjustments to the estimated fair value of the assets acquired and liabilities assumed, with the corresponding offset to goodwill. The results of operations of an acquired business is included in our consolidated financial statements from the date of acquisition. Acquisition-related expenses are expensed as incurred.
Goodwill
Goodwill represents the excess of the purchase price consideration over the estimated fair value of the tangible and intangible assets acquired and liabilities assumed in a business combination. Goodwill is evaluated for impairment annually in the fourth quarter of our fiscal year as a single reporting unit, and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. We may elect to qualitatively assess whether it is more likely than not that the fair value of our reporting unit is less than its carrying value. If we opt not to qualitatively assess, a quantitative goodwill impairment test is performed. The quantitative test compares our reporting unit's carrying amount, including goodwill, to its fair value calculated based on our enterprise value. If the carrying amount exceeds its fair value, an impairment loss is recognized for the excess.
Purchased Intangible Assets
Purchased intangible assets with finite lives are stated at cost, net of accumulated amortization. We amortize our intangible assets on a straight-line basis over an estimated useful life of three to seven years.
Impairment of Long-Lived Assets
We review our long-lived assets, including property and equipment and finite-lived intangible assets, for impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. We measure the recoverability of these assets by comparing the carrying amounts to the future undiscounted cash flows the assets are expected to generate. If the total of the future undiscounted cash flows is less than the carrying amount of an asset, we record an impairment charge for the amount by which the carrying amount of the asset exceeds its fair value.
Convertible Senior Notes
Prior to the adoption of Accounting Standards Update (ASU) 2020-06 on February 7, 2022, in accounting for the issuance of our convertible senior notes (the Notes), we separated the Notes into liability and equity components. The carrying amount of the liability component was determined by measuring the fair value of a similar debt instrument that does not have an associated convertible feature. The carrying amount of the equity component representing the conversion option was calculated by deducting the fair value of the liability component from the principal amount of the Notes as a whole. This difference represented a debt discount that was amortized to interest expense using the effective interest method over the term of the Notes. The equity component of the Notes was included in additional paid-in capital in the consolidated balance sheets and was not remeasured as it continued to meet the conditions for equity classification. Transaction costs related to the issuance of the Notes (debt issuance costs) were allocated to the liability and equity components using the same proportions as the initial carrying value of the Notes. The debt issuance costs attributable to the liability component were netted with the principal amount of the Notes and amortized to interest expense using the effective interest method over the term of the Notes. The debt issuance costs attributable to the equity component were netted with the equity component of the Notes in additional paid-in capital.
Upon adoption of ASU 2020-06, we combined the liability and equity components assuming that the instrument was accounted for as a single liability from inception to the date of adoption, resulting in the elimination of the debt discount. Similarly, the liability and equity components of the debt issuance costs were combined as a reduction to the Notes and is being amortized to interest expense using the effective interest method over the remaining term of the Notes.
Deferred Commissions
Deferred commissions consist of incremental costs paid to our sales force to obtain customer contracts. Deferred commissions related to product revenue are recognized upon transfer of control to customers and deferred commissions related to subscription services revenue are amortized over an expected useful life of six years. We determine the expected useful life based on an estimated benefit period by evaluating our technology development life cycle, expected customer relationship period and other factors. We classify deferred commissions as current and non-current on our consolidated balance sheets based on the timing of when we expect to recognize the expense. Amortization of deferred commissions is included in sales and marketing expense in the consolidated statements of operations.
Leases
We determine if an arrangement contains a lease at inception and classify leases as an operating or finance lease at commencement date. Lease liabilities are recognized at the present value of the future lease payments at commencement date. The interest rate implicit in our operating and finance leases is not readily determinable, and therefore an incremental borrowing rate is estimated to determine the present value of future payments. The estimated incremental borrowing rate factors in a hypothetical interest rate on a collateralized basis with similar terms, payments, and economic environments. The lease right-of-use (ROU) asset is determined based on the lease liability initially established and reduced for any prepaid lease payments and any lease incentives. We account for the lease and non-lease components of operating and finance lease contract consideration as a single lease component.
Certain of the operating lease agreements contain rent concession, rent escalation, and option to renew provisions. Rent concession and rent escalation provisions are considered in determining the lease cost. Lease cost under our operating leases is recognized on a straight-line basis over the lease term commencing on the date we have the right to use the leased property. For finance leases, we recognize amortization expense of the finance lease ROU asset on a straight-line basis over the shorter of its useful life or lease term and record interest expense for finance lease liabilities based on the incremental borrowing rate. We generally use the base, non-cancelable, lease term when recognizing the lease assets and liabilities, unless it is reasonably certain that an extension or termination option will be exercised. Assets recognized and the short and long-term lease liabilities from finance leases are included in property and equipment, net, accrued expenses and other liabilities and other liabilities, non-current in the consolidated balance sheets.
In addition, certain of our operating lease agreements contain tenant improvement allowances from our landlords. These allowances are accounted for as lease incentives and reduce our ROU asset and lease cost over the lease term.
For short-term leases (defined as leases that, at the commencement date, have a lease term of twelve months or less, and do not include an option to purchase the underlying asset that we are reasonably certain to exercise), we recognize rent expense in our consolidated statements of operations on a straight-line basis over the lease term and record variable lease payments as incurred.
Deferred Revenue
Deferred revenue primarily consists of amounts that have been invoiced but have not yet been recognized as revenue and performance obligations pertaining to subscription services. The current portion of deferred revenue represents the amounts that are expected to be recognized as revenue within one year of the consolidated balance sheet dates.
Revenue Recognition
We generate revenue from two sources: (1) product revenue which includes the sale of integrated storage hardware and embedded licensed operating system software and (2) subscription services revenue which includes our portfolio of Evergreen offerings and Portworx. Subscription services revenue also include our professional services offerings such as installation and implementation consulting services.
We typically recognize product revenue upon transfer of control to our customers and the satisfaction of our performance obligations. For Evergreen//Flex, product revenue is recognized upon the commencement of the underlying subscription services. Products are typically shipped directly by us to customers.
Our subscription services revenue is derived from the services we perform in connection with the sale of subscription services and is recognized ratably over the contractual term, which generally ranges from one to six years. The majority of our product solutions are sold with an Evergreen subscription service agreement, which typically commences upon transfer of control of the corresponding products to our customers. Costs for subscription services are expensed when incurred. In addition, our Evergreen subscription provides our customers with a new controller based upon certain contractual terms. The controller refresh represents a separate performance obligation that is included within the Evergreen subscription service agreement and the allocated revenue is recognized upon shipment of the controller.
Our Evergreen subscription services also include the right to receive unspecified software updates and upgrades on a when-and-if-available basis, software bug fixes, replacement parts and other services related to the underlying infrastructure, as well as access to our cloud-based management and support platform. We also sell professional services such as installation and implementation consulting services and the related revenue is recognized as services are performed.
We recognize revenue upon the transfer of promised goods or services to customers in an amount that reflects the consideration we expect to be entitled in exchange for those goods or services. This is achieved through applying the following five-step approach:
Identification of the contract, or contracts, with a customer
Identification of the performance obligations in the contract
Determination of the transaction price
Allocation of the transaction price to the performance obligations in the contract
Recognition of revenue when, or as, we satisfy a performance obligation
When applying this five-step approach, we apply judgment in determining the customer's ability and intention to pay, which is based on a variety of factors including the customer's historical payment experience and/or published credit and financial information pertaining to the customer. To the extent a customer contract includes multiple promised goods or services, we determine whether promised goods or services should be accounted for as a separate performance obligation. The transaction price is determined based on the consideration which we will be entitled to in exchange for transferring goods or services to the customer. For contracts that contain multiple performance obligations, we allocate the transaction price to each performance obligation based on a relative standalone selling price (SSP). The SSP is determined based on the price at which the performance obligation is sold separately, or if not observable through past transactions, is estimated taking into account available information such as market conditions and internally approved pricing guidelines related to performance obligations.
Warranty
We generally provide a three-year warranty on hardware and a 90-day warranty on our software embedded in the hardware. Our hardware warranty provides for parts replacement for defective components and our software warranty provides for bug fixes. Our Evergreen subscription agreement provides for the same parts replacement that customers are entitled to under our warranty program, except that replacement parts are delivered according to targeted response times to minimize disruption to our customers’ critical business applications. Substantially all customers purchase Evergreen subscription agreements. We will establish a warranty reserve for specifically identified products if and when we determine we have systemic product failure. Our estimate for future estimated costs related to warranty activities is based upon historical product failure rates and historical costs incurred in correcting product failures. Warranty reserve at the end of fiscal 2023 was $7.4 million.
Research and Development
Research and development costs are expensed as incurred. Research and development costs consist primarily of employee compensation and related expenses, prototype expenses, to the extent there is no alternative use for that equipment, depreciation of equipment used in research and development, third-party engineering and contractor support costs, data center and cloud services costs as well as allocated overhead costs.
Capitalized Internal-Use Software Costs
We expense costs to develop software that is externally marketed before technological feasibility is reached. We have determined that technological feasibility is reached shortly before the release of our products and as a result, the development costs incurred after the establishment of technological feasibility and before the release of those products have not been significant and accordingly, all related software development costs have been expensed as incurred.
We capitalize (i) costs incurred to develop or modify software solely for our internal use, including hosted applications used to deliver our support services, and (ii) certain implementation costs incurred in a hosting arrangement that is a service contract when the preliminary project stage is complete, management with the relevant authority authorizes and commits to the funding of the software project, and it is probable the project will be completed and used to perform the intended function. Costs related to preliminary project activities and post implementation activities are expensed as incurred.
Software development costs are capitalized to property, plant and equipment and amortized using the straight-line method over an estimated useful life of four years. Software development costs capitalized to property and equipment were $7.8 million and $7.3 million for fiscal 2022 and 2023. Amortization expense for software development costs was none during fiscal 2021 and 2022 and $2.2 million during fiscal 2023.
Software implementation costs are capitalized to either prepaid and other current assets or other assets, non-current on our consolidated balance sheet and amortized over the terms of the associated hosting arrangements. Software implementation costs capitalized were $3.5 million and $9.3 million for fiscal 2022 and 2023. Amortization expense for software implementation costs was $0.1 million, $0.5 million and $1.5 million during fiscal 2021, 2022 and 2023.
Advertising Expenses
Advertising costs are expensed as incurred. Advertising expenses were $8.1 million, $15.3 million and $11.1 million for fiscal 2021, 2022 and 2023.
Stock-Based Compensation
Stock-based compensation includes expenses related to restricted stock units (RSUs), performance restricted stock units (PRSUs), restricted stock, stock options and purchase rights issued to employees under our employee stock purchase plan (ESPP). RSUs, PRSUs and restricted stock are measured at the fair market value of the underlying stock at the grant date. We determine the fair value of purchase rights issued to employees under our ESPP and our stock options under our equity plans on the date of grant utilizing the Black-Scholes option pricing model, which is impacted by the fair value of our common stock, as well as changes in assumptions regarding a number of subjective variables. These variables include the expected common stock price volatility over the term of the awards, the expected term of the awards, risk-free interest rates and expected dividend yield. 
We recognize stock-based compensation expense for stock-based awards with only service conditions on a straight-line basis over the period during which an employee is required to provide services in exchange for the award (generally the vesting period of the award). We account for forfeitures as they occur. For stock-based awards granted to employees with a performance condition, we recognize stock-based compensation expense for these awards under the accelerated attribution method over the requisite service period when management determines it is probable that the performance condition will be satisfied.
Income Taxes
We account for income taxes using the asset and liability method. Deferred income taxes are recognized by applying enacted statutory tax rates applicable to future years to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The measurement of deferred tax assets is reduced, if necessary, by a valuation allowance to amounts that are more likely than not to be realized.
We recognize tax benefits from uncertain tax positions only if we believe that it is more likely than not that the tax position will be sustained on examination by the taxing authorities based on the technical merits of the position. The tax benefits recognized in the financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement.
Recently Adopted Accounting Pronouncement
In August 2020, the FASB issued ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity's Own Equity, which simplifies the accounting for certain convertible instruments, amends guidance on derivative scope exceptions for contracts in an entity's own equity, and requires the use of the if-converted method to calculate the impact of convertible instruments on diluted earnings per share (EPS) which results in the inclusion of the effect of share settlement for instruments that may be settled in cash or shares. We adopted this standard as of February 7, 2022 using the modified retrospective basis, under which financial results reported in prior periods were not adjusted. Adoption resulted in an adjustment of $133.3 million to reclassify the remaining balance of the conversion feature recorded in additional paid-in capital to the Notes of $35.2 million and accumulated deficit of $98.1 million on the consolidated balance sheet. Accordingly, we no longer carry an equity component of the Notes. For further information, see Note 7, Debt, and Note 13, Net Income (Loss) per Share Attributable to Common Stockholders.
Recent Accounting Pronouncements
v3.23.1
Financial Instruments
12 Months Ended
Feb. 05, 2023
Investments, Debt and Equity Securities [Abstract]  
Financial Instruments Financial Instruments
Fair Value Measurements
We define fair value as the exchange price that would be received from sale of an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. We measure our financial assets and liabilities at fair value at each reporting period using a fair value hierarchy which requires us to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement.
Three levels of inputs may be used to measure fair value:
Level 1 - Observable inputs are unadjusted quoted prices in active markets for identical assets or liabilities;
Level 2 - Observable inputs are quoted prices for similar assets and liabilities in active markets or inputs other than quoted prices that are observable for the assets or liabilities, either directly or indirectly through market corroboration, for substantially the full term of the financial instruments; and
Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. These inputs are based on our own assumptions used to measure assets and liabilities at fair value and require significant management judgment or estimation.
Cash Equivalents, Marketable Securities and Restricted Cash
We measure our cash equivalents, marketable securities and restricted cash at fair value on a recurring basis. We classify our cash equivalents, marketable securities and restricted cash within Level 1 or Level 2 because they are valued using either quoted market prices or inputs other than quoted prices which are directly or indirectly observable in the market, including readily-available pricing sources for the identical underlying security which may not be actively traded. Our fixed income available-for-sale securities consist of high quality, investment grade securities from diverse issuers. The valuation techniques used to measure the fair value of our marketable securities were derived from non-binding market consensus prices that are corroborated by observable market data or quoted market prices for similar instruments.
The following tables summarize our cash equivalents, marketable securities and restricted cash by significant investment categories and their classification within the fair value hierarchy at the end of fiscal 2022 and 2023 (in thousands):
 At the End of Fiscal 2022
 Amortized Cost Gross Unrealized GainsGross Unrealized LossesFair ValueCash EquivalentsMarketable SecuritiesRestricted Cash
Level 1    
Money market accounts$— $— $— $29,275 $18,731 $— $10,544 
Level 2    
U.S. government treasury notes336,303 512 (2,176)334,639 — 334,639 — 
U.S. government agencies49,153 49 (193)49,009 — 49,009 — 
Corporate debt securities491,728 384 (4,731)487,381 200 487,181 — 
Foreign government bonds12,333 37 (17)12,353 — 12,353 — 
Asset-backed securities60,361 111 (453)60,019 — 60,019 — 
Municipal bonds3,950 — (78)3,872 — 3,872 — 
       Total $953,828 $1,093 $(7,648)$976,548 $18,931 $947,073 $10,544 
 At the End of Fiscal 2023
 Amortized Cost Gross Unrealized GainsGross Unrealized LossesFair ValueCash EquivalentsMarketable SecuritiesRestricted Cash
Level 1    
Money market accounts$— $— $— $49,733 $39,189 $— $10,544 
Level 2
U.S. government treasury notes425,977 170 (4,229)421,918 32,008 389,910 — 
U.S. government agencies23,795 — (289)23,506 — 23,506 — 
Corporate debt securities527,164 901 (9,300)518,765 — 518,765 — 
Foreign government bonds4,797 — (44)4,753 — 4,753 — 
Asset-backed securities61,371 281 (1,016)60,636 — 60,636 — 
Municipal bonds3,950 — (168)3,782 — 3,782 — 
Total$1,047,054 $1,352 $(15,046)$1,083,093 $71,197 $1,001,352 $10,544 
The amortized cost and estimated fair value of our marketable securities are shown below by contractual maturity (in thousands):
At the End of Fiscal 2023
 Amortized CostFair Value
Due within one year$542,675 $537,272 
Due in one to five years468,427 460,091 
Due in five to ten years3,944 3,989 
  Total$1,015,046 $1,001,352 
Unrealized losses on our debt securities have not been recorded into income because we do not intend to sell nor is it more likely than not that we will be required to sell these investments prior to recovery of their amortized cost basis. The decline in fair value of our debt securities is largely due to the rising interest rate environment driven by current market conditions that has resulted in higher credit spreads. The credit ratings associated with our debt securities are mostly unchanged, are highly rated and the issuers continue to make timely principal and interest payments. As a result, there were no credit or non-credit impairment charges recorded in fiscal 2021, 2022, and 2023. The following table presents gross unrealized losses and fair values for those investments that were in a continuous unrealized loss position at the end of fiscal 2022 and 2023, aggregated by investment category (in thousands):

At the End of Fiscal 2022
Less than 12 monthsGreater than 12 monthsTotal
Fair ValueUnrealized LossFair ValueUnrealized LossFair ValueUnrealized Loss
U.S. government treasury notes$193,359 $(2,176)$— $— $193,359 $(2,176)
U.S. government agencies24,388 (193)— — 24,388 (193)
Corporate debt securities374,223 (4,708)1,182 (23)375,405 (4,731)
Foreign government bonds4,098 (17)— — 4,098 (17)
Asset-backed securities37,608 (453)— — 37,608 (453)
Municipal bonds3,872 (78)— — 3,872 (78)
Total$637,548 $(7,625)$1,182 $(23)$638,730 $(7,648)
At the End of Fiscal 2023
Less than 12 monthsGreater than 12 monthsTotal
 Fair ValueUnrealized LossFair ValueUnrealized LossFair ValueUnrealized Loss
U.S. government treasury notes$250,046 $(130)$127,976 $(4,099)$378,022 $(4,229)
U.S. government agencies5,194 (5)18,312 (284)23,506 (289)
Corporate debt securities 99,446 (330)277,717 (8,970)377,163 (9,300)
Foreign government bonds3,200 (5)551 (39)3,751 (44)
Asset-backed securities3,060 (25)22,221 (991)25,281 (1,016)
Municipal bonds— — 3,782 (168)3,782 (168)
     Total$360,946 $(495)$450,559 $(14,551)$811,505 $(15,046)
Realized gains or losses on sale of marketable securities were not significant for all periods presented.
Other Financial Instruments
We measure the fair value of our Notes on a quarterly basis and we determined the fair value of the Notes at the end of fiscal 2022 and 2023 to be a Level 2 measurement due to its limited trading activity. Refer to Note 7 for the net carrying amounts and estimated fair value of the Notes at the end of fiscal 2022 and 2023.
v3.23.1
Business Combination
12 Months Ended
Feb. 05, 2023
Business Combination and Asset Acquisition [Abstract]  
Business Combination Business Combination
In October 2020, we acquired all outstanding stock of Portworx Inc. (Portworx), a privately-held container storage company that provides a Kubernetes data services platform for cloud native applications. The transaction costs associated with the acquisition were not material and expensed as incurred. The total purchase consideration for the acquisition of Portworx was $352.9 million, which consisted of the following (in thousands):
Cash$344,049 
Fair value of options assumed8,802 
Total$352,851 
We assumed certain unvested and outstanding stock options for Portworx's common stock. These stock options were converted into 1.9 million stock options for shares of our common stock. The fair value of the exchanged options determined using the Black-Scholes option pricing model was $26.8 million, of which $8.8 million attributable to services performed prior to the acquisition date was allocated to purchase consideration. The remaining fair value of $18.0 million was allocated to future services and is being expensed over the remaining service periods as stock-based compensation expense. In addition, we assumed 2.0 million RSUs outstanding with a fair value of $31.8 million that is being recognized as stock-based compensation expense over a four year vesting period.
The following table summarizes the fair values of assets acquired and liabilities assumed as of the date of the acquisition (in thousands):
AmountEstimated Useful Life
Goodwill$321,152 
Identified intangible assets:
Developed technology21,273 5 years
Customer relationships6,459 7 years
Trade name3,623 3 years
Cash4,407 
Net liabilities assumed(4,063)
Total$352,851 
Goodwill generated from this acquisition was primarily attributable to the assembled workforce and expected post-acquisition synergies from combining Portworx container data services with our data services platform to expand our capabilities to support Kubernetes and containers. Goodwill was not deductible for tax purposes. The fair values of developed technology, customer relationships and trade name were derived by applying the excess earnings method, with-and-without method, and the relief-from-royalty method, respectively, all of which are under the income approach whose underlying inputs are considered Level 3. The fair values assigned to assets acquired and liabilities assumed were based on management's estimates and assumptions.
In connection with the Portworx acquisition, we recorded a net deferred tax asset of $14.7 million. However, this amount was offset by a valuation allowance, thus, resulting in a net zero deferred tax asset during fiscal 2021. We continue to maintain a valuation allowance for our U.S. federal and state deferred tax assets.
In addition, cash payments to certain former shareholders of Portworx totaling $32.2 million are being made over three years subject to continuous employment and are recognized as an operating expense. The remaining unpaid amount was $4.9 million at the end of fiscal 2023.
The results of Portworx have been included in our consolidated statements of operations since the acquisition date and are not material. Pro forma results of operations have not been presented because the acquisition was not material to our results of operations.
v3.23.1
Balance Sheet Components
12 Months Ended
Feb. 05, 2023
Balance Sheet Components Disclosure [Abstract]  
Balance Sheet Components Balance Sheet Components
Inventory
Inventory consists of the following (in thousands):
At the End of Fiscal
20222023
Raw materials$15,734 $24,896 
Finished goods23,208 25,256 
Inventory$38,942 $50,152 
Property and Equipment, Net
Property and equipment, net consists of the following (in thousands):
 At the End of Fiscal
 20222023
Test equipment$266,672 $315,290 
Computer equipment and software206,053 262,574 
Furniture and fixtures8,652 9,693 
Leasehold improvements47,443 71,235 
Capitalized software development costs8,528 15,806 
Total property and equipment537,348 674,598 
Less: accumulated depreciation and amortization(342,066)(402,153)
Property and equipment, net$195,282 $272,445 
Depreciation and amortization expense related to property and equipment was $57.1 million, $65.9 million and $87.0 million for fiscal 2021, 2022 and 2023, respectively.
Intangible Assets, Net
Intangible assets, net consist of the following (in thousands):
 
At the End of Fiscal
 20222023
 Gross Carrying ValueAccumulated AmortizationNet Carrying AmountGross Carrying ValueAccumulated AmortizationNet Carrying Amount
Technology patents$19,125 $(13,544)$5,581 $19,125 $(14,826)$4,299 
Developed technology80,166 (30,304)49,862 83,211 (43,366)39,845 
Customer relationships6,459 (1,246)5,213 6,459 (2,166)4,293 
Trade name3,623 (1,633)1,990 3,623 (2,838)785 
Intangible assets, net$109,373 $(46,727)$62,646 $112,418 $(63,196)$49,222 
Intangible assets amortization expense was $13.0 million, $16.8 million and $16.5 million for fiscal 2021, 2022 and 2023, respectively. At the end of fiscal 2023, the weighted-average remaining amortization period was 1.6 years for technology patents, 3.0 years for developed technology, 4.7 years for customer relationships, and 0.6 years for trade name. We recorded amortization of technology patents in general and administrative expenses due to their defensive nature, developed technology in cost of product revenue, and customer relationships and trade name in sales and marketing expenses in the consolidated statements of operations.
At the end of fiscal 2023, future expected amortization expense for intangible assets is as follows (in thousands):
Fiscal Years Ending Future Expected 
Amortization
Expense
2024$16,210 
202515,425 
202612,830 
20273,107 
20281,054 
Thereafter596 
Total$49,222 
Goodwill
The change in the carrying amount of goodwill is as follows (in thousands):
Amount
Balance as of the end of fiscal 2022
$358,736 
Goodwill acquired2,691 
Balance as of the end of fiscal 2023
$361,427 
There were no impairments to goodwill during fiscal 2022 and 2023.
Accrued Expenses and Other Liabilities
Accrued expenses and other liabilities consist of the following (in thousands):
 At the End of Fiscal
 20222023
Taxes payable $6,312 $16,615 
Accrued marketing13,257 14,228 
Accrued cloud and outside services6,135 7,644 
Supply chain-related accruals (1)
6,991 23,545 
Accrued service logistics and professional services6,244 7,927 
Acquisition earn-out and deferred consideration5,211 3,556 
Finance lease liabilities, current1,035 5,432 
Customer deposits from contracts with customers10,409 17,824 
Other accrued liabilities22,917 26,978 
Total accrued expenses and other liabilities$78,511 $123,749 
_________________________________
(1) Primarily consist of warranty reserves and accruals related to our inventory and inventory purchase commitments with our contract manufacturers.
v3.23.1
Deferred Revenue and Commissions
12 Months Ended
Feb. 05, 2023
Revenue from Contract with Customer [Abstract]  
Deferred Revenue and Commissions Deferred Revenue and Commissions
Deferred Commissions
Changes in total deferred commissions during the periods presented are as follows (in thousands):
Fiscal Year Ended
20222023
Beginning balance$187,924 $246,307 
Additions217,595 155,414 
Recognition of deferred commissions(159,212)(155,865)
Ending balance$246,307 $245,856 
During fiscal 2021, 2022 and 2023, we recognized sales commission expenses of $150.2 million, $175.9 million, and $170.0 million, respectively. Of the $245.9 million total deferred commissions balance at the end of fiscal 2023, we expect to recognize approximately 28% as sales commission expense over the next 12 months and the remainder thereafter.
There was no impairment related to capitalized commissions for fiscal 2021, 2022 or 2023.
Deferred Revenue
Changes in total deferred revenue during the periods presented are as follows (in thousands):
Fiscal Year Ended
20222023
Beginning balance$843,697 $1,079,872 
Additions937,510 1,248,417 
Recognition of deferred revenue(701,335)(942,639)
Ending balance $1,079,872 $1,385,650 
During fiscal 2022 and 2023, we recognized approximately $442.7 million and $567.8 million, respectively, in revenue pertaining to deferred revenue as of the beginning of each period.
Remaining Performance Obligations
Total remaining performance obligations (RPO) which is contracted but not recognized revenue was $1.8 billion at the end of fiscal 2023. RPO consists of both deferred revenue and non-cancelable amounts that are expected to be invoiced and recognized as revenue in future periods. Product orders are generally cancelable until delivery has occurred, and as such unfulfilled product orders are excluded from RPO. Of the $1.8 billion RPO at the end of fiscal 2023, we expect to recognize approximately 47% over the next 12 months, and the remainder thereafter.
v3.23.1
Debt
12 Months Ended
Feb. 05, 2023
Debt Disclosure [Abstract]  
Debt Debt
Convertible Senior Notes
In April 2018, we issued $575.0 million in principal amount of 0.125% convertible senior notes due 2023, in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act and received proceeds of $562.1 million, after deducting the underwriters’ discounts and commissions. The Notes are governed by an indenture (the Indenture) between us, as the issuer, and U.S. Bank National Association, as trustee. The Notes are our senior unsecured obligations. The Indenture does not contain any financial covenants or restrictions on the payments of dividends, the incurrence of indebtedness, or the issuance or repurchase of securities by us or any of our subsidiaries. The Notes will mature on April 15, 2023. Interest is payable semi-annually in arrears on April 15 and October 15 of each year.
The Notes are convertible for up to 21,884,155 shares of our common stock at an initial conversion rate of approximately 38.0594 shares of common stock per $1,000 principal amount, which is equal to an initial conversion price of approximately $26.27 per share of common stock, subject to adjustment. On October 14, 2022, we provided notice to the holders electing to settle all conversions on or after October 15, 2022 with cash up to the principal amount of the Notes and shares for any excess conversion value.
The conversion price will be subject to adjustment in some events. Following certain corporate events that occur prior to the maturity date or following our issuance of a notice of redemption, we will increase the conversion rate for a holder who elects to convert its Notes in connection with such corporate event or during the related redemption period in certain circumstances. Additionally, upon the occurrence of a corporate event that constitutes a “fundamental change” per the Indenture, holders of the Notes may require us to repurchase for cash all or a portion of the Notes at a purchase price equal to 100% of the principal amount of the Notes plus accrued and unpaid contingent interest.
The Notes consisted of the following (in thousands):
At the End of Fiscal
20222023
Liability:
Principal$575,000 $575,000 
Less: debt discount, net of amortization (1)
(35,641)— 
Less: debt issuance costs, net of amortization (1)
(2,580)(494)
Net carrying amount of the Notes$536,779 $574,506 
Stockholders' equity recorded at issuance:
Allocated value of the conversion feature (1)
$136,333 $— 
Less: debt issuance costs (1)
(3,068)— 
Additional paid-in capital$133,265 $— 
_________________________________
(1) Fiscal 2023 reflects the adoption of ASU 2020-06 on February 7, 2022 using the modified retrospective method as described in Note 2.
The total estimated fair values of the Notes at the end of fiscal 2022 and 2023 were $681.8 million and $660.0 million. The fair values were determined based on the closing trading price per $100 of the Notes as of the last day of trading of fiscal 2022 and 2023. The fair value of the Notes is primarily affected by the trading price of our common stock and market interest rates. Based on the closing price of our common stock of $29.91 on the last day of fiscal 2023, the if-converted value of the Notes of $654.6 million was greater than its principal amount. At the end of fiscal 2023, the remaining term of the Notes is approximately two months.
The following table sets forth total interest expense recognized related to the Notes (in thousands):
Fiscal Year Ended
20222023
Amortization of debt discount (1)
$28,874 $— 
Amortization of debt issuance costs (1)
2,091 2,598 
Total amortization of debt discount and debt issuance costs30,965 2,598 
Contractual interest expense732 716 
Total interest expense related to the Notes$31,697 $3,314 
Effective interest rate of the liability component5.6 %0.6 %
_________________________________
(1) Fiscal 2023 reflects the adoption of ASU 2020-06 on February 7, 2022 using the modified retrospective method as described in Note 2.
In connection with the offering of the Notes, we paid $64.6 million to enter into capped call transactions with certain of the underwriters and their affiliates (the Capped Calls), whereby we have the option to purchase up to a total of 21,884,155 shares of our common stock to offset the dilution and/or any cash payments we are required to make in excess of the principal amount upon conversion of the Notes at maturity, with such offset subject to a cap of $39.66 per share (which represents a premium of 100% over the last reported sales price of our common stock on April 4, 2018), subject to certain adjustments (the Cap Price). However, for conversions prior to maturity, the Capped Calls would be settled at their fair value, which may not completely offset, and may be substantially less than, the value of the consideration in excess of the principal amount of the Notes delivered upon such conversion. The cost of the Capped Calls was accounted for as a reduction to additional paid-in capital on the consolidated balance sheets.
Impact on Earnings Per Share
Subsequent to the adoption of ASU 2020-06, we compute the potentially dilutive shares of common stock related to the Notes for periods we report net income using the if-converted method. Upon conversion at maturity, there will be no economic dilution from the Notes until the average market price of our common stock exceeds the Cap Price of $39.66 per share as the exercise of the Capped Calls would offset any dilution from the Notes from the conversion price up to the Cap Price. Capped Calls are excluded from the calculation of diluted earnings per share, as they would be anti-dilutive.
Revolving Credit Facility
In August 2020, we entered into a Credit Agreement with a consortium of financial institutions and lenders that provides for a five-year, senior secured revolving credit facility of $300.0 million (Credit Facility). Proceeds from the Credit Facility may be used for general corporate purposes and working capital. The Credit Facility expires, absent default or early termination by us, on the earlier of (i) August 24, 2025 or (ii) 91 days prior to the stated maturity of the Notes unless, on such date and each subsequent day until the Notes are paid in full, the sum of our cash, cash equivalents and marketable securities and the aggregate unused commitments then available to us exceed $625.0 million.
The annual interest rates applicable to loans under the Credit Facility are, at our option, equal to either a base rate plus a margin ranging from 0.50% to 1.25% or LIBOR (based on one, three or six-month interest periods), subject to a floor of 0%, plus a margin ranging from 1.50% to 2.25%. Interest on revolving loans is payable quarterly in arrears with respect to loans based on the base rate and at the end of an interest period in the case of loans based on LIBOR (or at each three-month interval if the interest period is longer than three months). We are also required to pay a commitment fee on the unused portion of the commitments ranging from 0.25% to 0.40% per annum, payable quarterly in arrears. In March 2021, the ICE Benchmark Administration, the administrator of LIBOR, announced that it will cease publication of LIBOR by June 2023. In March 2023, we amended the Credit Facility to transition LIBOR to the Secured Overnight Financing Rate (SOFR) effective April 1, 2023. The annual interest rate for SOFR borrowings will be equal to term SOFR (based on one, three or six-month interest periods), subject to a floor of 0%, plus a margin ranging from 1.50% to 2.25%.
In February 2022, we repaid, in full, the $250.0 million outstanding under the Credit Facility. Prior to repayment, the outstanding loan bore weighted-average interest at the one-month LIBOR of approximately 1.65% and 1.60% resulting in interest expense of $1.4 million and $4.1 million during fiscal 2021 and 2022 and 1.61% resulting in interest expense of $0.3 million during the first quarter of fiscal 2023.
Loans under the Credit Facility are collateralized by substantially all of our assets and subject to certain restrictions and two financial ratios measured as of the last day of each fiscal quarter: a Consolidated Leverage Ratio not to exceed 4.5:1 and an Interest Coverage Ratio not to be less than 3:1. We were in compliance with all covenants under the Credit Facility at the end of fiscal 2023.
v3.23.1
Commitments and Contingencies
12 Months Ended
Feb. 05, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Leases
At the end of fiscal 2023, we had various non-cancelable operating and finance lease commitments for office facilities. Refer to Note 9—Leases for additional information regarding lease commitments.
Contractual Purchase Obligations
At the end of fiscal 2023, we had $445.0 million of non-cancelable contractual purchase obligations primarily related to inventory purchase commitments, software service contracts, and hosting arrangements. In order to manage future demand for our products, we enter into agreements with manufacturers and suppliers to procure inventory based upon our demand forecasts.
Letters of Credit
At the end of fiscal 2022 and 2023, we had outstanding letters of credit in the aggregate amount of $6.7 million and $8.0 million in connection with our facility leases. The letters of credit are collateralized by either restricted cash or the Credit Facility and mature on various dates through September 2030.
Legal Matters
From time to time, we have become involved in claims and other legal matters arising in the normal course of business. We investigate these claims as they arise. Although claims are inherently unpredictable, we currently are not aware of any matters that we expect to have a material adverse effect on our business, financial position, results of operations or cash flows. Accordingly, no material loss contingency has been recorded on our consolidated balance sheet as of the end of fiscal 2023.
Indemnification
Our arrangements generally include certain provisions for indemnifying customers against liabilities if our products or services infringe a third party’s intellectual property rights. Other guarantees or indemnification arrangements include guarantees of product and service performance and standby letters of credit for lease facilities. It is not possible to determine the maximum potential amount under these indemnification obligations due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each particular agreement. To date, we have not incurred any material costs as a result of such obligations and have not accrued any liabilities related to such obligations in the consolidated financial statements. In addition, we indemnify our officers, directors and certain key employees while they are serving in good faith in their respective capacities. To date, there have been no claims under any indemnification provisions.
v3.23.1
Leases
12 Months Ended
Feb. 05, 2023
Leases [Abstract]  
Leases LeasesWe lease office facilities under non-cancelable operating lease agreements expiring through July 2032. Our lease agreements do not contain any material residual value guarantees or restrictive covenants.
In June 2022, we entered into an eight-year sublease through July 2030 for a new headquarters facility in Santa Clara, California with total lease payments of $100.2 million that include rent escalation and abatement clauses. The sublease of space with total lease payments of $89.4 million commenced in August 2022. Additional space with lease payments of $10.8 million will commence in May 2024 and end in July 2030 and therefore are excluded from our future lease payments disclosure below.
During fiscal 2021, we ceased use of certain leased facilities that resulted in the recognition of certain exit costs - see Note 10 for further information.
We also lease certain engineering test equipment under financing agreements. These finance leases are three years and contain a bargain purchase option at the end of the respective lease term. It is reasonably certain that the bargain purchase option will be exercised.
The components of lease costs were as follows (in thousands):
Fiscal Year Ended
202120222023
Fixed operating lease cost$37,411 $37,598 $47,533 
Variable lease cost (1)
9,168 10,228 8,521 
Short-term lease cost (12 months or less)5,734 4,178 3,787 
Finance lease cost:
Amortization of finance lease right-of-use assets— 384 3,028 
Interest on finance lease liabilities— 42 330 
Total finance lease cost$— $426 $3,358 
Total lease cost$52,313 $52,430 $63,199 
_________________________________
(1) Variable lease cost predominantly included common area maintenance charges.
Supplemental information related to leases is as follows (in thousands):
Fiscal Year Ended
20222023
Operating leases:
Weighted-average remaining lease term (in years)4.55.2
Weighted-average discount rate5.7 %6.1 %
Finance leases:
Finance lease right-of-use assets, gross (1)
$3,577 $17,596 
     Accumulated amortization(1)
(384)(3,412)
Finance lease right-of-use assets, net (1)
$3,193 $14,184 
Finance lease liabilities, current (2)
1,035 5,432 
Finance lease liabilities, non-current (3)
1,487 4,765 
Total finance lease liabilities$2,522 $10,197 
Weighted-average remaining lease term (in years)3.63.3
Weighted-average discount rate2.7 %5.1 %
____________________________________
(1) Included in the consolidated balance sheets within property and equipment, net.
(2) Included in the consolidated balance sheets within accrued expenses and other liabilities.
(3) Included in the consolidated balance sheets within other liabilities, non-current.
Supplemental cash flow information related to leases is as follows (in thousands):
Fiscal Year Ended
20222023
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash outflows for operating leases$36,648 $49,955 
Financing cash outflows for finance leases$1,000 $6,138 
Right-of-use assets obtained in exchange for lease liabilities:
Operating leases$7,517 $80,962 
Finance leases$3,577 $14,019 
Future lease payments under our non-cancelable leases at the end of fiscal 2023 are as follows (in thousands):
Fiscal Years EndingOperating LeasesFinance Leases
2024$45,153 $5,839 
202548,315 4,728 
202636,366 183 
202719,384 — 
202821,062 — 
Thereafter44,274 — 
Total future lease payments$214,554 $10,750 
Less: imputed interest(38,374)(553)
Present value of total lease liabilities$176,180 $10,197 
v3.23.1
Restructuring and Other
12 Months Ended
Feb. 05, 2023
Restructuring and Related Activities [Abstract]  
Restructuring and Other Restructuring and Other
During fiscal 2021, we carried out the following restructuring and other activities:
We ceased use of certain leased facilities and recorded an impairment charge of $7.5 million for operating lease right-of-use assets and leasehold improvements for these leases. In addition, we recognized a liability of $2.4 million for the remaining lease costs that will continue to be incurred without benefit to us.
We effected workforce realignment plans to streamline our operations and recognized $12.2 million of restructuring costs related to one-time involuntary termination benefit costs. The restructuring charges are included in restructuring and other expenses in our consolidated statement of operations. All amounts were paid prior to the end of fiscal 2022.
We incurred incremental costs of $9.8 million directly related to the COVID-19 pandemic. These costs primarily included the write-off of marketing commitments no longer deemed to have value for the remainder of fiscal 2021, estimated non-recoverable costs for internal events that could not be held, and hazard related premiums to support manufacturing operations. Of these costs, $8.9 million is included in restructuring and other expenses and $0.9 million is included in cost of revenue in our consolidated statements of operations for fiscal 2021.
v3.23.1
Stockholders' Equity
12 Months Ended
Feb. 05, 2023
Equity [Abstract]  
Stockholders’ Equity Stockholders’ Equity
Preferred Stock
We have 20,000,000 authorized shares of undesignated preferred stock, the rights, preferences and privileges of which may be designated from time to time by our Board of Directors. At the end of fiscal 2023, there were no shares of preferred stock issued or outstanding.
Class A and Class B Common Stock
We have two classes of authorized common stock, Class A common stock, which we refer to as our "common stock", and Class B common stock. We have 2,000,000,000 authorized shares of Class A common stock and 250,000,000 authorized shares of Class B common stock, with each class having a par value of $0.0001 per share. At the end of fiscal 2023, 304,076,234 shares of Class A common stock were issued and outstanding.
Common Stock Reserved for Issuance
At the end of fiscal 2023, we had reserved shares of common stock for future issuance as follows:
Shares underlying outstanding stock options9,268,498 
Shares underlying outstanding restricted stock units26,760,520 
Shares reserved for future equity awards20,661,582 
Shares reserved for future employee stock purchase plan awards5,309,812 
Total62,000,412 
Share Repurchase Program
In August 2019, our Board of Directors approved a stock repurchase program to repurchase up to $150.0 million of our common stock, which was completed in the fourth quarter of fiscal 2021. In February 2021, our Board of Directors authorized the repurchase of up to an additional $200.0 million of our common stock, which was completed in the fourth quarter of fiscal 2022. In March 2022, our Board of Directors authorized the repurchase of up to an additional $250.0 million of our common stock, of which $31.1 million remained available at the end of fiscal 2023. In March 2023, our Board of Directors authorized the repurchase of up to an additional $250.0 million of our common stock. The authorization allows us to repurchase shares of our common stock opportunistically and will be funded from available working capital. Repurchases may be made at management’s discretion from time to time on the open market through privately negotiated transactions, transactions structured through investment banking institutions, block purchase techniques, 10b5-1 trading plans, or a combination of the foregoing. The share repurchase program does not obligate us to acquire any of our common stock, has no end date, and may be suspended or discontinued by us at any time without prior notice.
We record the difference between cash paid for stock repurchases and underlying par value as a reduction to additional paid-in capital, to the extent the repurchases does not cause this balance to be reduced below zero, at which point the difference would be recorded as a reduction to accumulated deficit. During fiscal 2021, we repurchased and retired 9,526,556 shares of common stock at an average purchase price of $14.17 per share for an aggregate repurchase price of $135.0 million. During fiscal 2022, we repurchased and retired 8,489,168 shares of common stock at an average purchase price of $23.56 per share for an aggregate repurchase price of $200.0 million. During fiscal 2023, we repurchased and retired 7,832,229 shares of common stock at an average purchase price of $27.95 per share for an aggregate repurchase price of $218.9 million. Since the end of fiscal 2023, we have repurchased $31.1 million of additional shares.
v3.23.1
Equity Incentive Plans
12 Months Ended
Feb. 05, 2023
Share-Based Payment Arrangement [Abstract]  
Equity Incentive Plans Equity Incentive Plans
Equity Incentive Plans
We maintain two equity incentive plans: the 2009 Equity Incentive Plan (the 2009 Plan) and the 2015 Equity Incentive Plan (the 2015 Plan). The 2015 Plan serves as the successor to our 2009 Plan and provides for grants of incentive stock options to our employees and non-statutory stock options, stock appreciation rights, restricted stock, RSUs, performance stock awards, performance cash awards, and other forms of stock awards to our employees, directors and consultants. Our equity awards generally vest over a two to four year period and expire no later than ten years from the date of grant. Starting in the fourth quarter of fiscal 2018, we discontinued granting stock options.
We initially reserved 27,000,000 shares of our common stock for issuance under our 2015 Plan. The number of shares reserved for issuance under our 2015 Plan increases automatically on the first day of each fiscal year, for a period of not more than ten years, commencing on February 1, 2016, in an amount equal to 5% of the total number of shares of our capital stock outstanding as of the immediately preceding January 31 (the Evergreen Increase). In March 2022, our Board of Directors approved an amendment and restatement of the 2015 Plan to clarify the effect of our change to a 52/53 week fiscal year in September 2019 on the Evergreen Increase.
We net-share settle equity awards held by certain employees by withholding shares upon vesting to satisfy tax withholding obligations. The shares withheld to satisfy employee tax withholding obligations are returned to our 2015 Plan and will be available for future issuance. Payments for employees’ tax obligations to the tax authorities are recognized as a reduction to additional paid-in capital and reflected as a financing activity in our consolidated statements of cash flows.
2015 Amended and Restated Employee Stock Purchase Plan
Our 2015 Employee Stock Purchase Plan was amended and restated in fiscal 2020 (2015 ESPP). A total of 3,500,000 shares of common stock was initially reserved for issuance under the 2015 ESPP and an additional 5,000,000 shares of common stock were added in connection with the amendment and restatement. The number of shares reserved for issuance under our 2015 ESPP increases automatically on the first day of February of each of 2016 through 2025, in an amount equal to the lesser of (i) 1% of the total number of shares of our capital stock outstanding as of the immediately preceding January 31, and (ii) 3,500,000 shares of common stock.
Our Board of Directors (or a committee thereof) has the authority to establish the length and terms of the offering periods and purchase periods and the purchase price of the shares of common stock which may be purchased under the plan. The current offering terms allow eligible employees to purchase shares of our common stock at a discount through payroll deductions of up to 30% of their eligible compensation, subject to a cap of 3,000 shares on any purchase date, a dollar cap of $7,500 per purchase period, or $25,000 in any calendar year (as determined under applicable tax rules). The current terms also allow for a 24-month offering period beginning March 16th and September 16th of each year, with each offering period consisting of four 6 month purchase periods, subject to a reset provision. Further, currently, on each purchase date, eligible employees may purchase our common stock at a price per share equal to 85% of the lesser of the fair market value of our common stock (1) on the first trading day of the applicable offering period or (2) the purchase date.
Under the reset provision currently authorized, if the closing stock price on the offering date of a new offering falls below the closing stock price on the offering date of an ongoing offering, the ongoing offering would terminate immediately following the purchase of ESPP shares on the purchase date immediately preceding the new offering and participants in the terminated ongoing offering would automatically be enrolled in the new offering (ESPP reset), resulting in a modification charge to be recognized over the new offering period. During fiscal 2021 and 2023, ESPP resets resulted in total modification charges of $23.8 million and $10.4 million, respectively, to be recognized over their new offering periods. There was no ESPP reset during fiscal 2022.
During fiscal 2021, 2022 and 2023, we recognized $25.8 million, $35.4 million and $22.9 million, of stock-based compensation expense related to our 2015 ESPP. At the end of fiscal 2023, total unrecognized stock-based compensation cost related to our 2015 ESPP was $31.5 million, which is expected to be recognized over a weighted-average period of approximately 1.6 years.
Stock Options
A summary of the stock option activity under our equity incentive plans and related information is as follows:
 Options Outstanding
 Number of
Shares
Weighted-
Average
Exercise Price
Weighted-
Average
Remaining
Contractual
Life (Years)
Aggregate
Intrinsic
Value
(in thousands)
Balance at the end of fiscal 202212,268,938 $10.25 3.5$198,266 
Options exercised(2,988,068)8.29   
Options forfeited(12,372)1.83   
Balance at the end of fiscal 20239,268,498 $10.90 2.7$176,674 
Vested and exercisable at the end of fiscal 20239,077,014 $11.04 2.6$171,315 
The aggregate intrinsic value of options vested and exercisable at the end of fiscal 2023 is calculated based on the difference between the exercise price and the closing price of $29.91 of our common stock on the last day of fiscal 2023. The aggregate intrinsic value of options exercised during fiscal 2021, 2022 and 2023 was $118.8 million, $105.1 million and $63.5 million.
The total grant date fair value of options vested during fiscal 2021, 2022 and 2023 was $20.1 million, $16.5 million and $7.0 million.
During fiscal 2021, 2022 and 2023, we recognized $8.6 million, $7.7 million and $4.9 million, of stock-based compensation expense related to stock options. At the end of fiscal 2023, total unrecognized employee stock-based compensation cost related to outstanding options was $2.4 million, which is expected to be recognized over a weighted-average period of 1.1 years.
Determination of Fair Value
The fair value of stock options granted to employees and to be purchased under ESPP is estimated on the grant date using the Black-Scholes option pricing model. This valuation model for stock-based compensation expense requires us to make assumptions and judgments about the variables used in the calculation including the fair value of the underlying common stock, expected term, the expected volatility of the common stock, a risk-free interest rate and expected dividend yield. The assumptions used for the periods presented are as follows:
 Fiscal Year Ended
 202120222023
Employee Stock Options   
Expected term (in years)5.65n/an/a
Expected volatility52.07%n/an/a
Risk-free interest rate0.3%n/an/a
Dividend raten/an/a
Fair value of common stock$15.79n/an/a
Employee Stock Purchase Plan   
Expected term (in years)
0.5 - 2.0
0.5 - 2.0
0.5 - 2.0
Expected volatility
52% - 113%
44% - 61%
45% - 54%
Risk-free interest rate
0.1% - 0.4%
0.1% - 0.2%
0.9% - 4.0%
Dividend rate
Fair value of common stock
$9.07 - $15.26
$23.63 - $26.69
$28.73 - $31.68
The assumptions used in the Black-Scholes option pricing model were determined as follows.
Fair Value of Common Stock—We use the market closing price of our common stock as reported on the New York Stock Exchange to determine the fair value of our common stock at each grant date.
Expected Term—The expected term represents the period that our stock-based awards are expected to be outstanding. The expected term assumptions were determined based on the vesting terms, exercise terms and contractual lives of the stock options and ESPP purchase rights.
Expected Volatility—The expected volatility for stock options and ESPP purchase rights is based on the historical volatility of our common stock for a period equivalent to the expected term of the stock option grants and ESPP purchase rights.
Risk-Free Interest Rate—The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for zero-coupon U.S. Treasury notes with maturities approximately equal to the expected term of the stock option grants and ESPP purchase rights.
Dividend Rate—We have never declared or paid any cash dividends and do not plan to pay cash dividends in the foreseeable future, and, therefore, use an expected dividend yield of zero.
RSUs and PRSUs
A summary of the RSU and PRSU activity under our equity incentive plans and related information is as follows:
Number of RSUs and PRSUs OutstandingWeighted-Average Grant Date Fair ValueAggregate Intrinsic Value
(in thousands)
Unvested balance at the end of fiscal 202228,712,878 $19.53 $757,446 
Granted15,319,768 29.67 
Vested(13,915,802)20.05 
Forfeited(3,356,324)21.75 
Unvested balance at the end of fiscal 202326,760,520 $24.78 $800,407 
During fiscal 2023, we granted 1,147,187 shares of PRSUs, at a target percentage of 100%, with both performance and service vesting conditions payable in common stock, from 0% to 150% of the target number granted, contingent upon the degree to which the fiscal 2023 performance condition is met. A total of 1,770,282 shares of PRSUs were earned at the end of fiscal 2023 based on the fiscal 2023 performance conditions achieved and a portion of these shares are subject to service conditions through the remaining vesting periods. The incremental shares of PRSUs earned will be granted in the first quarter of fiscal 2024.
The aggregate fair value, as of the respective vesting dates, of RSUs and PRSUs that vested during fiscal 2021, 2022 and 2023 was $183.4 million, $322.2 million and $402.7 million.
During fiscal 2021, 2022 and 2023, we recognized $199.1 million, $242.1 million and $299.7 million in stock-based compensation expense related to RSUs and PRSUs. At the end of fiscal 2023, total unrecognized employee compensation cost related to unvested RSUs and PRSUs was $588.4 million, which is expected to be recognized over a weighted-average period of 2.7 years.
Restricted Stock
A summary of the restricted stock activity under our 2015 Plan and related information is as follows:
 Number of Restricted Stock OutstandingWeighted-
Average
Grant Date
Fair Value
Aggregate
Intrinsic
Value
(in thousands)
Unvested balance at the end of fiscal 202254,977 $20.02 $1,450 
Vested(54,977)20.02 
Forfeited— — 
Unvested balance at the end of fiscal 2023— $— $— 
The aggregate fair value of restricted stock that vested during fiscal 2021, 2022 and 2023 was $18.3 million, $10.4 million and $1.9 million.
During fiscal 2021 and 2022, we recognized $9.3 million and $1.8 million in stock-based compensation expense related to restricted stock. The remaining stock-based compensation expense recognized related to restricted stock was not material during fiscal 2023.
Stock-Based Compensation Expense
The following table summarizes the components of stock-based compensation expense recognized in the consolidated statements of operations (in thousands):
 Fiscal Year Ended
 202120222023
Cost of revenue—product$4,001 $6,334 $10,245 
Cost of revenue—subscription services14,979 21,240 22,630 
Research and development117,220 142,264 161,694 
Sales and marketing65,248 71,439 72,507 
General and administrative40,896 45,686 60,541 
Total stock-based compensation expense$242,344 $286,963 $327,617 
The tax benefit related to stock-based compensation expense for all periods presented was not material.
v3.23.1
Net Income (Loss) per Share Attributable to Common Stockholders
12 Months Ended
Feb. 05, 2023
Earnings Per Share [Abstract]  
Net Income (Loss) per Share Attributable to Common Stockholders Net Income (Loss) per Share Attributable to Common StockholdersBasic and diluted net income (loss) per share attributable to common stockholders is presented in conformity with the two-class method required for participating securities. Basic net income (loss) per share attributable to common stockholders is computed by dividing the net income (loss) attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period, less shares subject to repurchase. Diluted net income (loss) per share attributable to common stockholders is computed by giving effect to all potentially dilutive common stock equivalents, including our outstanding stock options, common stock related to unvested RSUs and PRSUs, unvested restricted stock, the shares underlying the conversion option in our Notes to the extent dilutive, and common stock issuable pursuant to the ESPP. The adoption of ASU 2020-06 at the beginning of fiscal 2023 eliminates the treasury stock method and instead requires the application of the if-converted method to calculate the impact of our Notes on diluted EPS. Using this method, the numerator is affected by adding back interest expense related to the Notes and the denominator is affected by including the effect of potential share settlement, if the effect is dilutive. All potentially dilutive common stock equivalents, including from our Notes, have been excluded from the calculation of diluted net loss per share attributable to common stockholders in periods of net loss as their effect is anti-dilutive.
The following table sets forth the computation of basic and diluted net income (loss) per share attributable to common stockholders (in thousands, except per share data):
 Fiscal Year Ended
 202120222023
Numerator:
Net income (loss) attributable to common stockholders, basic$(282,076)$(143,259)$73,071 
Add: Interest charges related to our Notes— — 3,314 
Net income (loss) attributable to common stockholders, diluted$(282,076)$(143,259)$76,385 
Denominator:
Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, basic267,824 285,882 299,478 
Add: Dilutive effect of common stock equivalents— — 39,706 
Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, diluted267,824 285,882 339,184 
Net income (loss) per share attributable to common stockholders, basic$(1.05)$(0.50)$0.24 
Net income (loss) per share attributable to common stockholders, diluted$(1.05)$(0.50)$0.23 
The following weighted-average outstanding shares of common stock equivalents were excluded from the computation of diluted net income (loss) per share attributable to common stockholders for the periods presented because including them would have been anti-dilutive (in thousands):
 Fiscal Year Ended
 202120222023
Stock options to purchase common stock23,180 15,686 10,516 
Unvested RSUs and PRSUs31,980 32,491 29,780 
Unvested restricted stock1,145 257 
Shares related to convertible senior notes21,884 21,884 — 
Shares issuable pursuant to the ESPP2,148 2,122 885 
Total80,337 72,440 41,187 
v3.23.1
Other Income (Expense), Net
12 Months Ended
Feb. 05, 2023
Other Income and Expenses [Abstract]  
Other Income (Expense), Net Other Income (Expense), Net
Other income (expense), net consists of the following (in thousands):
Fiscal Year Ended
202120222023
Interest income (1)
$17,442 $9,371 $17,320 
Interest expense (2)
(31,403)(36,677)(4,749)
Foreign currency transactions gains (losses)2,507 (5,235)(8,345)
Other income2,327 2,443 4,069 
Total other income (expense), net$(9,127)$(30,098)$8,295 
_________________________________
(1) Interest income includes interest income related to our cash, cash equivalents and marketable securities and non-cash interest income (expense) related to accretion (amortization) of the discount (premium) on marketable securities.
(2) Interest expense includes non-cash interest expense related to amortization of debt discount and debt issuance costs, contractual interest expense related to our debt and accretion of our finance lease liabilities.
v3.23.1
Income Taxes
12 Months Ended
Feb. 05, 2023
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
The geographical breakdown of income (loss) before provision for income taxes is as follows (in thousands):
 Fiscal Year Ended
 202120222023
Domestic$(312,119)$(192,058)$39,004 
International41,959 63,562 52,804 
Total$(270,160)$(128,496)$91,808 
The components of the provision for income taxes are as follows (in thousands):
 Fiscal Year Ended
 202120222023
Current:   
State$442 $592 $5,999 
Foreign8,006 12,525 12,020 
Total$8,448 $13,117 $18,019 
Deferred:   
Federal$(218)$— $(639)
State— — (99)
Foreign3,686 1,646 1,456 
Total$3,468 $1,646 $718 
Provision for income taxes$11,916 $14,763 $18,737 
 
The reconciliation of income taxes at the federal statutory income tax rate to the provision for income taxes is as follows (in thousands):
 Fiscal Year Ended
 202120222023
Tax at federal statutory rate$(56,734)$(26,984)$19,280 
State tax, net of federal benefit349 468 4,625 
Stock-based compensation expense(604)(19,658)(11,976)
Research and development tax credits(14,138)(16,783)(26,634)
U.S. taxes on foreign income14,021 25,059 19,065 
Foreign rate differential2,282 (1,698)(425)
Withholding tax34 143 2,339 
Change in valuation allowance63,146 48,270 10,631 
Non-deductible expenses— 4,381 2,091 
Other3,560 1,565 (259)
Provision for income taxes$11,916 $14,763 $18,737 
Deferred income taxes reflect the net effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of our deferred tax assets and liabilities were as follows (in thousands):
 At the End of Fiscal
 20222023
Deferred tax assets:  
Net operating loss carryforwards$369,904 $198,495 
Tax credit carryover134,085 171,775 
Accruals and reserves22,625 34,506 
Deferred revenue66,242 87,026 
Stock-based compensation expense25,247 25,564 
ASC 842 lease liabilities28,577 40,772 
Capitalized research and development— 154,027 
Other1,879 4,950 
Total deferred tax assets$648,559 $717,115 
Valuation allowance(554,553)(598,997)
Total deferred tax assets, net of valuation allowance$94,006 $118,118 
Deferred tax liabilities:  
Depreciation and amortization$(12,992)$(31,744)
Deferred commissions(53,219)(53,421)
Convertible debt(4,642)— 
ASC 842 right-of-use assets(24,608)(36,366)
Acquired intangibles and goodwill(6,850)(4,702)
Interest income(874)(2,521)
Total deferred tax liabilities$(103,185)$(128,754)
Net deferred tax liabilities$(9,179)$(10,636)
At the end of fiscal 2023, the undistributed earnings of $176.2 million from non-U.S. operations held by our foreign subsidiaries are designated as permanently reinvested outside the U.S. Accordingly, no additional U.S. income taxes or additional foreign withholding taxes have been provided thereon. Determination of the amount of unrecognized deferred tax liability related to these earnings is not practicable.
At the end of fiscal 2023, we had net operating loss carryforwards for federal income tax purposes of approximately $795.1 million and state income tax purposes of approximately $578.0 million. The federal net operating loss carryforwards have an indefinite life while the state net operating loss carryforwards begin to expire in 2025.
We had federal and state research and development tax credit carryforwards of approximately $134.2 million and $116.0 million at the end of fiscal 2023. The federal research and development tax credit carryforwards will expire commencing in 2028, while the state research and development tax credit carryforwards have no expiration date.
Starting in fiscal 2023, changes to Section 174 of the Internal Revenue Code made by the Tax Cuts and Jobs Act of 2017 no longer permit an immediate deduction for research and development expenditures in the tax year that such costs are incurred. These costs are capitalized resulting in an increase in deferred tax assets and state income taxes.
Realization of deferred tax assets is dependent on future taxable income, the existence and timing of which is uncertain. Based on our history of losses, management has determined that it is more likely than not that the U.S. deferred tax assets will not be realized, and accordingly has placed a full valuation allowance on the net U.S. deferred tax assets. The valuation allowance increased by $70.1 million and $44.4 million, respectively, during fiscal 2022 and 2023.
Utilization of the net operating loss carryforwards and credits may be subject to substantial annual limitation due to the ownership change limitations provided by Section 382 of the Internal Revenue Code of 1986, as amended, and similar state provisions. The annual limitation may result in the expiration of net operating losses and credits before utilization.
Uncertain Tax Positions
The activity related to the unrecognized tax benefits is as follows (in thousands):
 Fiscal Year Ended
 202120222023
Gross unrecognized tax benefits—beginning balance$28,570 $39,571 $51,582 
Decreases related to tax positions taken during prior years(345)(173)— 
Increases related to tax positions taken during prior years1,881 1,201 2,172 
Increases related to tax positions taken during current year
9,465 10,983 15,143 
Gross unrecognized tax benefits—ending balance$39,571 $51,582 $68,897 
At the end of fiscal 2023, our gross unrecognized tax benefit was approximately $68.9 million, $6.2 million of which if recognized, would have an impact on the effective tax rate.
At the end of fiscal 2023, we had no current or cumulative interest and penalties related to uncertain tax positions.
It is difficult to predict the final timing and resolution of any particular uncertain tax position. Based on our assessment, including experience and complex judgments about future events, we do not expect that changes in the liability for unrecognized tax benefits during the next twelve months will have a significant impact on our consolidated financial position or results of operations.
We file income tax returns in the U.S. federal jurisdiction as well as many U.S. states and foreign jurisdictions. The tax returns for fiscal years 2009 and forward remain open to examination by the major jurisdictions in which we are subject to tax. The tax returns for fiscal years outside the normal statutes of limitation remain open to audit by tax authorities due to tax attributes generated in those early years, which have been carried forward and may be audited in subsequent years when utilized.
v3.23.1
Segment Information
12 Months Ended
Feb. 05, 2023
Segment Reporting [Abstract]  
Segment Information Segment Information
Our chief operating decision maker is our Chief Executive Officer. Our chief operating decision maker reviews financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance. Accordingly, we have a single reportable segment.
Disaggregation of Revenue
The following table depicts the disaggregation of revenue by geographic area based on the billing address of our customers and is consistent with how we evaluate our financial performance (in thousands):
 Fiscal Year Ended
 202120222023
United States$1,195,428 $1,580,022 $1,971,757 
Rest of the world488,751 600,826 781,677 
Total revenue$1,684,179 $2,180,848 $2,753,434 

Long-Lived Assets by Geographic Area
Long-lived assets, which are comprised of property and equipment, net, by geographic area are summarized as follows (in thousands):
 At the End of Fiscal
 20222023
United States$187,228 $259,131 
Rest of the world8,054 13,314 
Total long-lived assets$195,282 $272,445 
v3.23.1
401(k) Plan
12 Months Ended
Feb. 05, 2023
Compensation Related Costs [Abstract]  
401(k) Plan 401(k) PlanWe have a 401(k) savings plan (the 401(k) plan) which qualifies as a deferred salary arrangement under section 401(k) of the Internal Revenue Code. Under the 401(k) plan, participating employees may elect to contribute up to 85% of their eligible compensation, subject to certain limitations. We currently match 50% of employees' contributions up to a maximum of $4,000 annually. Matching contributions immediately vest. Our contributions to the plan were $10.2 million, $11.1 million and $12.2 million during fiscal 2021, 2022 and 2023.
v3.23.1
Basis of Presentation and Summary of Significant Accounting Policies (Policies)
12 Months Ended
Feb. 05, 2023
Accounting Policies [Abstract]  
Basis of Presentation and Principles of Consolidation
Basis of Presentation and Principles of Consolidation
We operate using a 52/53 week fiscal year ending on the first Sunday after January 30. Fiscal 2021 and 2023 were both 52-week years that ended on January 31, 2021 and February 5, 2023, respectively. Fiscal 2022 was a 53-week year that ended on February 6, 2022. Unless otherwise stated, all dates refer to our fiscal years.
The consolidated financial statements include the accounts of the Company and our wholly owned subsidiaries and have been prepared in conformity with accounting principles generally accepted in the United States (U.S. GAAP). All intercompany balances and transactions have been eliminated in consolidation.
Foreign Currency
Foreign Currency
The functional currency of our foreign subsidiaries is the U.S. dollar. Transactions denominated in currencies other than the functional currency are remeasured to the functional currency at the average exchange rate in effect during the period. At the end of each reporting period, monetary assets and liabilities are remeasured using exchange rates in effect at the balance sheet date. Non-monetary assets and liabilities are remeasured at historical exchange rates. Foreign currency transaction gains and losses are recorded in other income (expense), net in the consolidated statements of operations.
Use of Estimates
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and accompanying notes. Actual results could differ from these estimates and assumptions due to risks and uncertainties. Such estimates include, but are not limited to, the determination of standalone selling price for revenue arrangements with multiple performance obligations when the price at which the performance obligation sold separately or observable past transactions are not available, useful lives of intangible assets and property and equipment, the period of benefit for deferred contract costs for commissions, stock-based compensation, provision for income taxes including related reserves, fair value of equity assumed, intangible and tangible assets acquired and liabilities assumed for business combinations. Management bases its estimates on historical experience and on various other assumptions which management believes to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.
Concentration Risk Concentration RiskFinancial instruments that are exposed to concentration of credit risk consist primarily of cash and cash equivalents, marketable securities, and accounts receivable.
Cash and Cash Equivalents
Cash and Cash Equivalents
Cash and cash equivalents consist of cash in banks and highly liquid investments, primarily money market accounts and U.S. government treasury notes, purchased with an original maturity of three months or less.
Marketable Securities
Marketable Securities
We classify our marketable securities as available-for-sale (AFS) at the time of purchase and reevaluate such classification at each balance sheet date. We may sell these securities at any time for use in current operations even if they have not yet reached maturity. As a result, we classify our securities, including those with maturities beyond twelve months, as current assets in the consolidated balance sheets. We carry these securities at estimated fair value and record unrealized gains and losses in accumulated other comprehensive income (loss), which is reflected as a component of stockholders' equity. We evaluate our AFS debt securities with an unamortized cost basis in excess of estimated fair value to determine what amount of that difference, if any, is caused by expected credit losses. Credit-related impairment losses, not to exceed the amount that fair value is less than the amortized cost basis, are recognized through an allowance for credit losses with changes in the allowance for credit losses recognized as a charge to other income (expense), net, in the consolidated statements of operations. Any remaining impairment is included in accumulated other comprehensive income (loss) as a component of stockholders' equity. Realized gains and losses from the sale of marketable securities are determined based on the specific identification method. Realized gains and losses are reported in other income (expense), net in the consolidated statements of operations.
Fair Value of Financial Instruments
Fair Value of Financial Instruments
The carrying value of our financial instruments, including cash equivalents, accounts receivable, accounts payable and accrued liabilities, approximates fair value.
Accounts Receivable and Allowance
Accounts Receivable and Allowance
Accounts receivable are recorded at the invoiced amount, and stated at realizable value, net of an allowance for doubtful accounts. Credit is extended to partners and customers based on an evaluation of their financial condition and other factors. We generally do not require collateral or other security to support accounts receivable. We perform ongoing credit evaluations and maintain an allowance for doubtful accounts.
We assess the collectability of the accounts by taking into consideration the aging of our trade receivables, historical experience, and management judgment. We write off trade receivables against the allowance when management determines a balance is uncollectible and no longer actively pursues collection of the receivable.
Restricted Cash Restricted CashRestricted cash is comprised of cash collateral for letters of credit related to our leases and for a vendor credit card program.
Inventory
Inventory
Inventory consists of finished goods and component parts, which are purchased from contract manufacturers. Product demonstration units, which we regularly sell, are the primary component of our inventories. Inventories are stated at the lower of cost or net realizable value. Cost is determined using the specific identification method for finished goods and weighted-average method for component parts. We account for excess and obsolete inventory by reducing the carrying value to the estimated net realizable value of the inventory based upon management’s assumptions about future demand and market conditions. In addition, we record a liability for firm, non-cancelable and unconditional purchase commitments with contract manufacturers and suppliers for quantities in excess of future demand forecasts consistent with excess and obsolete inventory valuations. Inventory write-offs were insignificant for fiscal 2021, 2022 and 2023.
Property and Equipment, Net
Property and Equipment, Net
Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation and amortization is computed using the straight-line method over the estimated useful lives of the respective assets (test equipment—4 years, computer equipment and software—4 to 5 years, furniture and fixtures—7 years). Leasehold improvements are amortized over the shorter of their estimated useful lives or the remaining lease term. Depreciation commences once the asset is placed in service.
In accordance with our accounting practices, we review the estimated useful lives of our property and equipment on an ongoing basis. In the first quarter of fiscal 2021, management determined that the estimated useful lives of its test equipment and certain computer equipment and software required revision. The estimated useful lives of test equipment and certain computer equipment and software were revised to 4 years. Previously, the estimated useful lives of these assets ranged from 2 to 3 years. The change in estimated useful lives was accounted for as a change in estimate and recognized on a prospective basis effective February 3, 2020. The effect of this change in estimate resulted in a reduction to depreciation expense of $23.6 million during fiscal 2021.
Business Combinations
Business Combinations
We allocate the purchase price to the assets acquired and liabilities assumed based on their estimated fair values. The excess of the purchase price over the fair values of the assets acquired and liabilities assumed is recorded as goodwill. During the measurement period, which may be up to one year from the acquisition date, we may record adjustments to the estimated fair value of the assets acquired and liabilities assumed, with the corresponding offset to goodwill. The results of operations of an acquired business is included in our consolidated financial statements from the date of acquisition. Acquisition-related expenses are expensed as incurred.
Goodwill
Goodwill
Goodwill represents the excess of the purchase price consideration over the estimated fair value of the tangible and intangible assets acquired and liabilities assumed in a business combination. Goodwill is evaluated for impairment annually in the fourth quarter of our fiscal year as a single reporting unit, and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. We may elect to qualitatively assess whether it is more likely than not that the fair value of our reporting unit is less than its carrying value. If we opt not to qualitatively assess, a quantitative goodwill impairment test is performed. The quantitative test compares our reporting unit's carrying amount, including goodwill, to its fair value calculated based on our enterprise value. If the carrying amount exceeds its fair value, an impairment loss is recognized for the excess.
Purchased Intangible Assets
Purchased Intangible Assets
Purchased intangible assets with finite lives are stated at cost, net of accumulated amortization. We amortize our intangible assets on a straight-line basis over an estimated useful life of three to seven years.
Impairment of Long-Lived Assets
Impairment of Long-Lived Assets
We review our long-lived assets, including property and equipment and finite-lived intangible assets, for impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. We measure the recoverability of these assets by comparing the carrying amounts to the future undiscounted cash flows the assets are expected to generate. If the total of the future undiscounted cash flows is less than the carrying amount of an asset, we record an impairment charge for the amount by which the carrying amount of the asset exceeds its fair value.
Convertible Senior Notes
Convertible Senior Notes
Prior to the adoption of Accounting Standards Update (ASU) 2020-06 on February 7, 2022, in accounting for the issuance of our convertible senior notes (the Notes), we separated the Notes into liability and equity components. The carrying amount of the liability component was determined by measuring the fair value of a similar debt instrument that does not have an associated convertible feature. The carrying amount of the equity component representing the conversion option was calculated by deducting the fair value of the liability component from the principal amount of the Notes as a whole. This difference represented a debt discount that was amortized to interest expense using the effective interest method over the term of the Notes. The equity component of the Notes was included in additional paid-in capital in the consolidated balance sheets and was not remeasured as it continued to meet the conditions for equity classification. Transaction costs related to the issuance of the Notes (debt issuance costs) were allocated to the liability and equity components using the same proportions as the initial carrying value of the Notes. The debt issuance costs attributable to the liability component were netted with the principal amount of the Notes and amortized to interest expense using the effective interest method over the term of the Notes. The debt issuance costs attributable to the equity component were netted with the equity component of the Notes in additional paid-in capital.
Upon adoption of ASU 2020-06, we combined the liability and equity components assuming that the instrument was accounted for as a single liability from inception to the date of adoption, resulting in the elimination of the debt discount. Similarly, the liability and equity components of the debt issuance costs were combined as a reduction to the Notes and is being amortized to interest expense using the effective interest method over the remaining term of the Notes.
Deferred Commissions
Deferred Commissions
Deferred commissions consist of incremental costs paid to our sales force to obtain customer contracts. Deferred commissions related to product revenue are recognized upon transfer of control to customers and deferred commissions related to subscription services revenue are amortized over an expected useful life of six years. We determine the expected useful life based on an estimated benefit period by evaluating our technology development life cycle, expected customer relationship period and other factors. We classify deferred commissions as current and non-current on our consolidated balance sheets based on the timing of when we expect to recognize the expense. Amortization of deferred commissions is included in sales and marketing expense in the consolidated statements of operations.
Leases
Leases
We determine if an arrangement contains a lease at inception and classify leases as an operating or finance lease at commencement date. Lease liabilities are recognized at the present value of the future lease payments at commencement date. The interest rate implicit in our operating and finance leases is not readily determinable, and therefore an incremental borrowing rate is estimated to determine the present value of future payments. The estimated incremental borrowing rate factors in a hypothetical interest rate on a collateralized basis with similar terms, payments, and economic environments. The lease right-of-use (ROU) asset is determined based on the lease liability initially established and reduced for any prepaid lease payments and any lease incentives. We account for the lease and non-lease components of operating and finance lease contract consideration as a single lease component.
Certain of the operating lease agreements contain rent concession, rent escalation, and option to renew provisions. Rent concession and rent escalation provisions are considered in determining the lease cost. Lease cost under our operating leases is recognized on a straight-line basis over the lease term commencing on the date we have the right to use the leased property. For finance leases, we recognize amortization expense of the finance lease ROU asset on a straight-line basis over the shorter of its useful life or lease term and record interest expense for finance lease liabilities based on the incremental borrowing rate. We generally use the base, non-cancelable, lease term when recognizing the lease assets and liabilities, unless it is reasonably certain that an extension or termination option will be exercised. Assets recognized and the short and long-term lease liabilities from finance leases are included in property and equipment, net, accrued expenses and other liabilities and other liabilities, non-current in the consolidated balance sheets.
In addition, certain of our operating lease agreements contain tenant improvement allowances from our landlords. These allowances are accounted for as lease incentives and reduce our ROU asset and lease cost over the lease term.
For short-term leases (defined as leases that, at the commencement date, have a lease term of twelve months or less, and do not include an option to purchase the underlying asset that we are reasonably certain to exercise), we recognize rent expense in our consolidated statements of operations on a straight-line basis over the lease term and record variable lease payments as incurred.
Deferred Revenue and Revenue Recognition
Deferred Revenue
Deferred revenue primarily consists of amounts that have been invoiced but have not yet been recognized as revenue and performance obligations pertaining to subscription services. The current portion of deferred revenue represents the amounts that are expected to be recognized as revenue within one year of the consolidated balance sheet dates.
Revenue Recognition
We generate revenue from two sources: (1) product revenue which includes the sale of integrated storage hardware and embedded licensed operating system software and (2) subscription services revenue which includes our portfolio of Evergreen offerings and Portworx. Subscription services revenue also include our professional services offerings such as installation and implementation consulting services.
We typically recognize product revenue upon transfer of control to our customers and the satisfaction of our performance obligations. For Evergreen//Flex, product revenue is recognized upon the commencement of the underlying subscription services. Products are typically shipped directly by us to customers.
Our subscription services revenue is derived from the services we perform in connection with the sale of subscription services and is recognized ratably over the contractual term, which generally ranges from one to six years. The majority of our product solutions are sold with an Evergreen subscription service agreement, which typically commences upon transfer of control of the corresponding products to our customers. Costs for subscription services are expensed when incurred. In addition, our Evergreen subscription provides our customers with a new controller based upon certain contractual terms. The controller refresh represents a separate performance obligation that is included within the Evergreen subscription service agreement and the allocated revenue is recognized upon shipment of the controller.
Our Evergreen subscription services also include the right to receive unspecified software updates and upgrades on a when-and-if-available basis, software bug fixes, replacement parts and other services related to the underlying infrastructure, as well as access to our cloud-based management and support platform. We also sell professional services such as installation and implementation consulting services and the related revenue is recognized as services are performed.
We recognize revenue upon the transfer of promised goods or services to customers in an amount that reflects the consideration we expect to be entitled in exchange for those goods or services. This is achieved through applying the following five-step approach:
Identification of the contract, or contracts, with a customer
Identification of the performance obligations in the contract
Determination of the transaction price
Allocation of the transaction price to the performance obligations in the contract
Recognition of revenue when, or as, we satisfy a performance obligation
When applying this five-step approach, we apply judgment in determining the customer's ability and intention to pay, which is based on a variety of factors including the customer's historical payment experience and/or published credit and financial information pertaining to the customer. To the extent a customer contract includes multiple promised goods or services, we determine whether promised goods or services should be accounted for as a separate performance obligation. The transaction price is determined based on the consideration which we will be entitled to in exchange for transferring goods or services to the customer. For contracts that contain multiple performance obligations, we allocate the transaction price to each performance obligation based on a relative standalone selling price (SSP). The SSP is determined based on the price at which the performance obligation is sold separately, or if not observable through past transactions, is estimated taking into account available information such as market conditions and internally approved pricing guidelines related to performance obligations.
Warranty WarrantyWe generally provide a three-year warranty on hardware and a 90-day warranty on our software embedded in the hardware. Our hardware warranty provides for parts replacement for defective components and our software warranty provides for bug fixes. Our Evergreen subscription agreement provides for the same parts replacement that customers are entitled to under our warranty program, except that replacement parts are delivered according to targeted response times to minimize disruption to our customers’ critical business applications. Substantially all customers purchase Evergreen subscription agreements. We will establish a warranty reserve for specifically identified products if and when we determine we have systemic product failure. Our estimate for future estimated costs related to warranty activities is based upon historical product failure rates and historical costs incurred in correcting product failures.
Research and Development Research and DevelopmentResearch and development costs are expensed as incurred. Research and development costs consist primarily of employee compensation and related expenses, prototype expenses, to the extent there is no alternative use for that equipment, depreciation of equipment used in research and development, third-party engineering and contractor support costs, data center and cloud services costs as well as allocated overhead costs.
Capitalized Internal-Use Software Costs
Capitalized Internal-Use Software Costs
We expense costs to develop software that is externally marketed before technological feasibility is reached. We have determined that technological feasibility is reached shortly before the release of our products and as a result, the development costs incurred after the establishment of technological feasibility and before the release of those products have not been significant and accordingly, all related software development costs have been expensed as incurred.
We capitalize (i) costs incurred to develop or modify software solely for our internal use, including hosted applications used to deliver our support services, and (ii) certain implementation costs incurred in a hosting arrangement that is a service contract when the preliminary project stage is complete, management with the relevant authority authorizes and commits to the funding of the software project, and it is probable the project will be completed and used to perform the intended function. Costs related to preliminary project activities and post implementation activities are expensed as incurred.
Software development costs are capitalized to property, plant and equipment and amortized using the straight-line method over an estimated useful life of four years. Software development costs capitalized to property and equipment were $7.8 million and $7.3 million for fiscal 2022 and 2023. Amortization expense for software development costs was none during fiscal 2021 and 2022 and $2.2 million during fiscal 2023.
Software implementation costs are capitalized to either prepaid and other current assets or other assets, non-current on our consolidated balance sheet and amortized over the terms of the associated hosting arrangements. Software implementation costs capitalized were $3.5 million and $9.3 million for fiscal 2022 and 2023. Amortization expense for software implementation costs was $0.1 million, $0.5 million and $1.5 million during fiscal 2021, 2022 and 2023.
Advertising Expenses Advertising ExpensesAdvertising costs are expensed as incurred.
Stock-Based Compensation
Stock-Based Compensation
Stock-based compensation includes expenses related to restricted stock units (RSUs), performance restricted stock units (PRSUs), restricted stock, stock options and purchase rights issued to employees under our employee stock purchase plan (ESPP). RSUs, PRSUs and restricted stock are measured at the fair market value of the underlying stock at the grant date. We determine the fair value of purchase rights issued to employees under our ESPP and our stock options under our equity plans on the date of grant utilizing the Black-Scholes option pricing model, which is impacted by the fair value of our common stock, as well as changes in assumptions regarding a number of subjective variables. These variables include the expected common stock price volatility over the term of the awards, the expected term of the awards, risk-free interest rates and expected dividend yield. 
We recognize stock-based compensation expense for stock-based awards with only service conditions on a straight-line basis over the period during which an employee is required to provide services in exchange for the award (generally the vesting period of the award). We account for forfeitures as they occur. For stock-based awards granted to employees with a performance condition, we recognize stock-based compensation expense for these awards under the accelerated attribution method over the requisite service period when management determines it is probable that the performance condition will be satisfied.
Income Taxes
Income Taxes
We account for income taxes using the asset and liability method. Deferred income taxes are recognized by applying enacted statutory tax rates applicable to future years to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The measurement of deferred tax assets is reduced, if necessary, by a valuation allowance to amounts that are more likely than not to be realized.
We recognize tax benefits from uncertain tax positions only if we believe that it is more likely than not that the tax position will be sustained on examination by the taxing authorities based on the technical merits of the position. The tax benefits recognized in the financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement.
Recently Adopted Accounting Pronouncements and Recent Accounting Pronouncements
Recently Adopted Accounting Pronouncement
In August 2020, the FASB issued ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity's Own Equity, which simplifies the accounting for certain convertible instruments, amends guidance on derivative scope exceptions for contracts in an entity's own equity, and requires the use of the if-converted method to calculate the impact of convertible instruments on diluted earnings per share (EPS) which results in the inclusion of the effect of share settlement for instruments that may be settled in cash or shares. We adopted this standard as of February 7, 2022 using the modified retrospective basis, under which financial results reported in prior periods were not adjusted. Adoption resulted in an adjustment of $133.3 million to reclassify the remaining balance of the conversion feature recorded in additional paid-in capital to the Notes of $35.2 million and accumulated deficit of $98.1 million on the consolidated balance sheet. Accordingly, we no longer carry an equity component of the Notes. For further information, see Note 7, Debt, and Note 13, Net Income (Loss) per Share Attributable to Common Stockholders.
Recent Accounting Pronouncements
There are no recently issued accounting pronouncements that are expected to have material impact on our consolidated financial statements and accompanying disclosures.
Fair Value Measurements
Fair Value Measurements
We define fair value as the exchange price that would be received from sale of an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. We measure our financial assets and liabilities at fair value at each reporting period using a fair value hierarchy which requires us to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement.
Three levels of inputs may be used to measure fair value:
Level 1 - Observable inputs are unadjusted quoted prices in active markets for identical assets or liabilities;
Level 2 - Observable inputs are quoted prices for similar assets and liabilities in active markets or inputs other than quoted prices that are observable for the assets or liabilities, either directly or indirectly through market corroboration, for substantially the full term of the financial instruments; and
Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. These inputs are based on our own assumptions used to measure assets and liabilities at fair value and require significant management judgment or estimation.
v3.23.1
Basis of Presentation and Summary of Significant Accounting Policies (Tables)
12 Months Ended
Feb. 05, 2023
Accounting Policies [Abstract]  
Schedule of Changes in Allowance for Doubtful Accounts
The following table presents the changes in the allowance for doubtful accounts:
 Fiscal Year Ended
 202120222023
 (in thousands) 
Allowance for doubtful accounts, beginning balance$542 $1,033 $945 
Provision, net of cash received496 (18)377 
Write-offs(5)(70)(265)
Allowance for doubtful accounts, ending balance$1,033 $945 $1,057 
v3.23.1
Financial Instruments (Tables)
12 Months Ended
Feb. 05, 2023
Investments, Debt and Equity Securities [Abstract]  
Schedule of Cash Equivalents, Marketable Securities and Restricted Cash
The following tables summarize our cash equivalents, marketable securities and restricted cash by significant investment categories and their classification within the fair value hierarchy at the end of fiscal 2022 and 2023 (in thousands):
 At the End of Fiscal 2022
 Amortized Cost Gross Unrealized GainsGross Unrealized LossesFair ValueCash EquivalentsMarketable SecuritiesRestricted Cash
Level 1    
Money market accounts$— $— $— $29,275 $18,731 $— $10,544 
Level 2    
U.S. government treasury notes336,303 512 (2,176)334,639 — 334,639 — 
U.S. government agencies49,153 49 (193)49,009 — 49,009 — 
Corporate debt securities491,728 384 (4,731)487,381 200 487,181 — 
Foreign government bonds12,333 37 (17)12,353 — 12,353 — 
Asset-backed securities60,361 111 (453)60,019 — 60,019 — 
Municipal bonds3,950 — (78)3,872 — 3,872 — 
       Total $953,828 $1,093 $(7,648)$976,548 $18,931 $947,073 $10,544 
 At the End of Fiscal 2023
 Amortized Cost Gross Unrealized GainsGross Unrealized LossesFair ValueCash EquivalentsMarketable SecuritiesRestricted Cash
Level 1    
Money market accounts$— $— $— $49,733 $39,189 $— $10,544 
Level 2
U.S. government treasury notes425,977 170 (4,229)421,918 32,008 389,910 — 
U.S. government agencies23,795 — (289)23,506 — 23,506 — 
Corporate debt securities527,164 901 (9,300)518,765 — 518,765 — 
Foreign government bonds4,797 — (44)4,753 — 4,753 — 
Asset-backed securities61,371 281 (1,016)60,636 — 60,636 — 
Municipal bonds3,950 — (168)3,782 — 3,782 — 
Total$1,047,054 $1,352 $(15,046)$1,083,093 $71,197 $1,001,352 $10,544 
Schedule of Amortized Cost and Estimated Fair Value
The amortized cost and estimated fair value of our marketable securities are shown below by contractual maturity (in thousands):
At the End of Fiscal 2023
 Amortized CostFair Value
Due within one year$542,675 $537,272 
Due in one to five years468,427 460,091 
Due in five to ten years3,944 3,989 
  Total$1,015,046 $1,001,352 
Schedule of Gross Unrealized Losses and Fair Values The following table presents gross unrealized losses and fair values for those investments that were in a continuous unrealized loss position at the end of fiscal 2022 and 2023, aggregated by investment category (in thousands):
At the End of Fiscal 2022
Less than 12 monthsGreater than 12 monthsTotal
Fair ValueUnrealized LossFair ValueUnrealized LossFair ValueUnrealized Loss
U.S. government treasury notes$193,359 $(2,176)$— $— $193,359 $(2,176)
U.S. government agencies24,388 (193)— — 24,388 (193)
Corporate debt securities374,223 (4,708)1,182 (23)375,405 (4,731)
Foreign government bonds4,098 (17)— — 4,098 (17)
Asset-backed securities37,608 (453)— — 37,608 (453)
Municipal bonds3,872 (78)— — 3,872 (78)
Total$637,548 $(7,625)$1,182 $(23)$638,730 $(7,648)
At the End of Fiscal 2023
Less than 12 monthsGreater than 12 monthsTotal
 Fair ValueUnrealized LossFair ValueUnrealized LossFair ValueUnrealized Loss
U.S. government treasury notes$250,046 $(130)$127,976 $(4,099)$378,022 $(4,229)
U.S. government agencies5,194 (5)18,312 (284)23,506 (289)
Corporate debt securities 99,446 (330)277,717 (8,970)377,163 (9,300)
Foreign government bonds3,200 (5)551 (39)3,751 (44)
Asset-backed securities3,060 (25)22,221 (991)25,281 (1,016)
Municipal bonds— — 3,782 (168)3,782 (168)
     Total$360,946 $(495)$450,559 $(14,551)$811,505 $(15,046)
v3.23.1
Business Combination (Tables)
12 Months Ended
Feb. 05, 2023
Business Combination and Asset Acquisition [Abstract]  
Schedule of Consideration Transferred The total purchase consideration for the acquisition of Portworx was $352.9 million, which consisted of the following (in thousands):
Cash$344,049 
Fair value of options assumed8,802 
Total$352,851 
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed
The following table summarizes the fair values of assets acquired and liabilities assumed as of the date of the acquisition (in thousands):
AmountEstimated Useful Life
Goodwill$321,152 
Identified intangible assets:
Developed technology21,273 5 years
Customer relationships6,459 7 years
Trade name3,623 3 years
Cash4,407 
Net liabilities assumed(4,063)
Total$352,851 
v3.23.1
Balance Sheet Components (Tables)
12 Months Ended
Feb. 05, 2023
Balance Sheet Components Disclosure [Abstract]  
Schedule of Inventory Inventory consists of the following (in thousands):
At the End of Fiscal
20222023
Raw materials$15,734 $24,896 
Finished goods23,208 25,256 
Inventory$38,942 $50,152 
Schedule of Property and Equipment, Net Property and equipment, net consists of the following (in thousands):
 At the End of Fiscal
 20222023
Test equipment$266,672 $315,290 
Computer equipment and software206,053 262,574 
Furniture and fixtures8,652 9,693 
Leasehold improvements47,443 71,235 
Capitalized software development costs8,528 15,806 
Total property and equipment537,348 674,598 
Less: accumulated depreciation and amortization(342,066)(402,153)
Property and equipment, net$195,282 $272,445 
Schedule of Intangible Assets, Net
Intangible assets, net consist of the following (in thousands):
 
At the End of Fiscal
 20222023
 Gross Carrying ValueAccumulated AmortizationNet Carrying AmountGross Carrying ValueAccumulated AmortizationNet Carrying Amount
Technology patents$19,125 $(13,544)$5,581 $19,125 $(14,826)$4,299 
Developed technology80,166 (30,304)49,862 83,211 (43,366)39,845 
Customer relationships6,459 (1,246)5,213 6,459 (2,166)4,293 
Trade name3,623 (1,633)1,990 3,623 (2,838)785 
Intangible assets, net$109,373 $(46,727)$62,646 $112,418 $(63,196)$49,222 
Schedule of Expected Amortization Expenses for Intangible Assets
At the end of fiscal 2023, future expected amortization expense for intangible assets is as follows (in thousands):
Fiscal Years Ending Future Expected 
Amortization
Expense
2024$16,210 
202515,425 
202612,830 
20273,107 
20281,054 
Thereafter596 
Total$49,222 
Schedule of Goodwill The change in the carrying amount of goodwill is as follows (in thousands):
Amount
Balance as of the end of fiscal 2022
$358,736 
Goodwill acquired2,691 
Balance as of the end of fiscal 2023
$361,427 
Schedule of Accrued Expenses and Other Liabilities
Accrued expenses and other liabilities consist of the following (in thousands):
 At the End of Fiscal
 20222023
Taxes payable $6,312 $16,615 
Accrued marketing13,257 14,228 
Accrued cloud and outside services6,135 7,644 
Supply chain-related accruals (1)
6,991 23,545 
Accrued service logistics and professional services6,244 7,927 
Acquisition earn-out and deferred consideration5,211 3,556 
Finance lease liabilities, current1,035 5,432 
Customer deposits from contracts with customers10,409 17,824 
Other accrued liabilities22,917 26,978 
Total accrued expenses and other liabilities$78,511 $123,749 
_________________________________
(1) Primarily consist of warranty reserves and accruals related to our inventory and inventory purchase commitments with our contract manufacturers.
v3.23.1
Deferred Revenue and Commissions (Tables)
12 Months Ended
Feb. 05, 2023
Revenue from Contract with Customer [Abstract]  
Schedule of Deferred Commissions
Changes in total deferred commissions during the periods presented are as follows (in thousands):
Fiscal Year Ended
20222023
Beginning balance$187,924 $246,307 
Additions217,595 155,414 
Recognition of deferred commissions(159,212)(155,865)
Ending balance$246,307 $245,856 
Schedule of Deferred Revenue
Changes in total deferred revenue during the periods presented are as follows (in thousands):
Fiscal Year Ended
20222023
Beginning balance$843,697 $1,079,872 
Additions937,510 1,248,417 
Recognition of deferred revenue(701,335)(942,639)
Ending balance $1,079,872 $1,385,650 
v3.23.1
Debt (Tables)
12 Months Ended
Feb. 05, 2023
Debt Disclosure [Abstract]  
Schedule of Convertible Debt
The Notes consisted of the following (in thousands):
At the End of Fiscal
20222023
Liability:
Principal$575,000 $575,000 
Less: debt discount, net of amortization (1)
(35,641)— 
Less: debt issuance costs, net of amortization (1)
(2,580)(494)
Net carrying amount of the Notes$536,779 $574,506 
Stockholders' equity recorded at issuance:
Allocated value of the conversion feature (1)
$136,333 $— 
Less: debt issuance costs (1)
(3,068)— 
Additional paid-in capital$133,265 $— 
_________________________________
(1) Fiscal 2023 reflects the adoption of ASU 2020-06 on February 7, 2022 using the modified retrospective method as described in Note 2.
Schedule of Interest Expense
The following table sets forth total interest expense recognized related to the Notes (in thousands):
Fiscal Year Ended
20222023
Amortization of debt discount (1)
$28,874 $— 
Amortization of debt issuance costs (1)
2,091 2,598 
Total amortization of debt discount and debt issuance costs30,965 2,598 
Contractual interest expense732 716 
Total interest expense related to the Notes$31,697 $3,314 
Effective interest rate of the liability component5.6 %0.6 %
_________________________________
(1) Fiscal 2023 reflects the adoption of ASU 2020-06 on February 7, 2022 using the modified retrospective method as described in Note 2.
v3.23.1
Leases (Tables)
12 Months Ended
Feb. 05, 2023
Leases [Abstract]  
Components of Lease Cost
The components of lease costs were as follows (in thousands):
Fiscal Year Ended
202120222023
Fixed operating lease cost$37,411 $37,598 $47,533 
Variable lease cost (1)
9,168 10,228 8,521 
Short-term lease cost (12 months or less)5,734 4,178 3,787 
Finance lease cost:
Amortization of finance lease right-of-use assets— 384 3,028 
Interest on finance lease liabilities— 42 330 
Total finance lease cost$— $426 $3,358 
Total lease cost$52,313 $52,430 $63,199 
_________________________________
(1) Variable lease cost predominantly included common area maintenance charges.
Supplemental information related to leases is as follows (in thousands):
Fiscal Year Ended
20222023
Operating leases:
Weighted-average remaining lease term (in years)4.55.2
Weighted-average discount rate5.7 %6.1 %
Finance leases:
Finance lease right-of-use assets, gross (1)
$3,577 $17,596 
     Accumulated amortization(1)
(384)(3,412)
Finance lease right-of-use assets, net (1)
$3,193 $14,184 
Finance lease liabilities, current (2)
1,035 5,432 
Finance lease liabilities, non-current (3)
1,487 4,765 
Total finance lease liabilities$2,522 $10,197 
Weighted-average remaining lease term (in years)3.63.3
Weighted-average discount rate2.7 %5.1 %
____________________________________
(1) Included in the consolidated balance sheets within property and equipment, net.
(2) Included in the consolidated balance sheets within accrued expenses and other liabilities.
(3) Included in the consolidated balance sheets within other liabilities, non-current.
Schedule of Cash Flow, Supplemental Disclosures
Supplemental cash flow information related to leases is as follows (in thousands):
Fiscal Year Ended
20222023
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash outflows for operating leases$36,648 $49,955 
Financing cash outflows for finance leases$1,000 $6,138 
Right-of-use assets obtained in exchange for lease liabilities:
Operating leases$7,517 $80,962 
Finance leases$3,577 $14,019 
Schedule of Future Lease Payments Under Non-Cancelable Leases
Future lease payments under our non-cancelable leases at the end of fiscal 2023 are as follows (in thousands):
Fiscal Years EndingOperating LeasesFinance Leases
2024$45,153 $5,839 
202548,315 4,728 
202636,366 183 
202719,384 — 
202821,062 — 
Thereafter44,274 — 
Total future lease payments$214,554 $10,750 
Less: imputed interest(38,374)(553)
Present value of total lease liabilities$176,180 $10,197 
v3.23.1
Stockholders' Equity (Tables)
12 Months Ended
Feb. 05, 2023
Equity [Abstract]  
Summary of Reserved Shares of Common Stock for Future Issuance
At the end of fiscal 2023, we had reserved shares of common stock for future issuance as follows:
Shares underlying outstanding stock options9,268,498 
Shares underlying outstanding restricted stock units26,760,520 
Shares reserved for future equity awards20,661,582 
Shares reserved for future employee stock purchase plan awards5,309,812 
Total62,000,412 
v3.23.1
Equity Incentive Plans (Tables)
12 Months Ended
Feb. 05, 2023
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Option Activity Under Equity Incentive Plans and Related Information
A summary of the stock option activity under our equity incentive plans and related information is as follows:
 Options Outstanding
 Number of
Shares
Weighted-
Average
Exercise Price
Weighted-
Average
Remaining
Contractual
Life (Years)
Aggregate
Intrinsic
Value
(in thousands)
Balance at the end of fiscal 202212,268,938 $10.25 3.5$198,266 
Options exercised(2,988,068)8.29   
Options forfeited(12,372)1.83   
Balance at the end of fiscal 20239,268,498 $10.90 2.7$176,674 
Vested and exercisable at the end of fiscal 20239,077,014 $11.04 2.6$171,315 
Summary of Estimate Fair Value of Employee Stock Options and Employee Purchase Plan The assumptions used for the periods presented are as follows:
 Fiscal Year Ended
 202120222023
Employee Stock Options   
Expected term (in years)5.65n/an/a
Expected volatility52.07%n/an/a
Risk-free interest rate0.3%n/an/a
Dividend raten/an/a
Fair value of common stock$15.79n/an/a
Employee Stock Purchase Plan   
Expected term (in years)
0.5 - 2.0
0.5 - 2.0
0.5 - 2.0
Expected volatility
52% - 113%
44% - 61%
45% - 54%
Risk-free interest rate
0.1% - 0.4%
0.1% - 0.2%
0.9% - 4.0%
Dividend rate
Fair value of common stock
$9.07 - $15.26
$23.63 - $26.69
$28.73 - $31.68
Schedule of Share-based Compensation, Restricted Stock Units Award Activity A summary of the RSU and PRSU activity under our equity incentive plans and related information is as follows:
Number of RSUs and PRSUs OutstandingWeighted-Average Grant Date Fair ValueAggregate Intrinsic Value
(in thousands)
Unvested balance at the end of fiscal 202228,712,878 $19.53 $757,446 
Granted15,319,768 29.67 
Vested(13,915,802)20.05 
Forfeited(3,356,324)21.75 
Unvested balance at the end of fiscal 202326,760,520 $24.78 $800,407 
Schedule of Restricted Stock Activity A summary of the restricted stock activity under our 2015 Plan and related information is as follows:
 Number of Restricted Stock OutstandingWeighted-
Average
Grant Date
Fair Value
Aggregate
Intrinsic
Value
(in thousands)
Unvested balance at the end of fiscal 202254,977 $20.02 $1,450 
Vested(54,977)20.02 
Forfeited— — 
Unvested balance at the end of fiscal 2023— $— $— 
Summarizes the Components of Stock-Based Compensation
The following table summarizes the components of stock-based compensation expense recognized in the consolidated statements of operations (in thousands):
 Fiscal Year Ended
 202120222023
Cost of revenue—product$4,001 $6,334 $10,245 
Cost of revenue—subscription services14,979 21,240 22,630 
Research and development117,220 142,264 161,694 
Sales and marketing65,248 71,439 72,507 
General and administrative40,896 45,686 60,541 
Total stock-based compensation expense$242,344 $286,963 $327,617 
v3.23.1
Net Income (Loss) per Share Attributable to Common Stockholders (Tables)
12 Months Ended
Feb. 05, 2023
Earnings Per Share [Abstract]  
Summary of Computation of Basic and Diluted Net Income (Loss) per Share Attributable to Common Stockholders
The following table sets forth the computation of basic and diluted net income (loss) per share attributable to common stockholders (in thousands, except per share data):
 Fiscal Year Ended
 202120222023
Numerator:
Net income (loss) attributable to common stockholders, basic$(282,076)$(143,259)$73,071 
Add: Interest charges related to our Notes— — 3,314 
Net income (loss) attributable to common stockholders, diluted$(282,076)$(143,259)$76,385 
Denominator:
Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, basic267,824 285,882 299,478 
Add: Dilutive effect of common stock equivalents— — 39,706 
Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, diluted267,824 285,882 339,184 
Net income (loss) per share attributable to common stockholders, basic$(1.05)$(0.50)$0.24 
Net income (loss) per share attributable to common stockholders, diluted$(1.05)$(0.50)$0.23 
Summary of Weighted-average Outstanding Shares Excluded from Computation of Diluted Net Income (Loss) per Share Attributable to Common Stockholders
The following weighted-average outstanding shares of common stock equivalents were excluded from the computation of diluted net income (loss) per share attributable to common stockholders for the periods presented because including them would have been anti-dilutive (in thousands):
 Fiscal Year Ended
 202120222023
Stock options to purchase common stock23,180 15,686 10,516 
Unvested RSUs and PRSUs31,980 32,491 29,780 
Unvested restricted stock1,145 257 
Shares related to convertible senior notes21,884 21,884 — 
Shares issuable pursuant to the ESPP2,148 2,122 885 
Total80,337 72,440 41,187 
v3.23.1
Other Income (Expense), Net (Tables)
12 Months Ended
Feb. 05, 2023
Other Income and Expenses [Abstract]  
Summary of Other Income (Expense)
Other income (expense), net consists of the following (in thousands):
Fiscal Year Ended
202120222023
Interest income (1)
$17,442 $9,371 $17,320 
Interest expense (2)
(31,403)(36,677)(4,749)
Foreign currency transactions gains (losses)2,507 (5,235)(8,345)
Other income2,327 2,443 4,069 
Total other income (expense), net$(9,127)$(30,098)$8,295 
_________________________________
(1) Interest income includes interest income related to our cash, cash equivalents and marketable securities and non-cash interest income (expense) related to accretion (amortization) of the discount (premium) on marketable securities.
(2) Interest expense includes non-cash interest expense related to amortization of debt discount and debt issuance costs, contractual interest expense related to our debt and accretion of our finance lease liabilities.
v3.23.1
Income Taxes (Tables)
12 Months Ended
Feb. 05, 2023
Income Tax Disclosure [Abstract]  
Schedule Of Geographical Breakdown Of Income (Loss) Before Provision For Income Taxes
The geographical breakdown of income (loss) before provision for income taxes is as follows (in thousands):
 Fiscal Year Ended
 202120222023
Domestic$(312,119)$(192,058)$39,004 
International41,959 63,562 52,804 
Total$(270,160)$(128,496)$91,808 
Schedule of Components of Provision for Income Taxes
The components of the provision for income taxes are as follows (in thousands):
 Fiscal Year Ended
 202120222023
Current:   
State$442 $592 $5,999 
Foreign8,006 12,525 12,020 
Total$8,448 $13,117 $18,019 
Deferred:   
Federal$(218)$— $(639)
State— — (99)
Foreign3,686 1,646 1,456 
Total$3,468 $1,646 $718 
Provision for income taxes$11,916 $14,763 $18,737 
Schedule of Reconciliation of the Federal Statutory Income Tax Rate and Effective Income Tax Rate
The reconciliation of income taxes at the federal statutory income tax rate to the provision for income taxes is as follows (in thousands):
 Fiscal Year Ended
 202120222023
Tax at federal statutory rate$(56,734)$(26,984)$19,280 
State tax, net of federal benefit349 468 4,625 
Stock-based compensation expense(604)(19,658)(11,976)
Research and development tax credits(14,138)(16,783)(26,634)
U.S. taxes on foreign income14,021 25,059 19,065 
Foreign rate differential2,282 (1,698)(425)
Withholding tax34 143 2,339 
Change in valuation allowance63,146 48,270 10,631 
Non-deductible expenses— 4,381 2,091 
Other3,560 1,565 (259)
Provision for income taxes$11,916 $14,763 $18,737 
Significant Components of Deferred Tax Assets and Liabilities The significant components of our deferred tax assets and liabilities were as follows (in thousands):
 At the End of Fiscal
 20222023
Deferred tax assets:  
Net operating loss carryforwards$369,904 $198,495 
Tax credit carryover134,085 171,775 
Accruals and reserves22,625 34,506 
Deferred revenue66,242 87,026 
Stock-based compensation expense25,247 25,564 
ASC 842 lease liabilities28,577 40,772 
Capitalized research and development— 154,027 
Other1,879 4,950 
Total deferred tax assets$648,559 $717,115 
Valuation allowance(554,553)(598,997)
Total deferred tax assets, net of valuation allowance$94,006 $118,118 
Deferred tax liabilities:  
Depreciation and amortization$(12,992)$(31,744)
Deferred commissions(53,219)(53,421)
Convertible debt(4,642)— 
ASC 842 right-of-use assets(24,608)(36,366)
Acquired intangibles and goodwill(6,850)(4,702)
Interest income(874)(2,521)
Total deferred tax liabilities$(103,185)$(128,754)
Net deferred tax liabilities$(9,179)$(10,636)
Summary of Activity Related to Unrecognized Tax Benefits
The activity related to the unrecognized tax benefits is as follows (in thousands):
 Fiscal Year Ended
 202120222023
Gross unrecognized tax benefits—beginning balance$28,570 $39,571 $51,582 
Decreases related to tax positions taken during prior years(345)(173)— 
Increases related to tax positions taken during prior years1,881 1,201 2,172 
Increases related to tax positions taken during current year
9,465 10,983 15,143 
Gross unrecognized tax benefits—ending balance$39,571 $51,582 $68,897 
v3.23.1
Segment Information (Tables)
12 Months Ended
Feb. 05, 2023
Segment Reporting [Abstract]  
Schedule of Revenue by Geographic Area
The following table depicts the disaggregation of revenue by geographic area based on the billing address of our customers and is consistent with how we evaluate our financial performance (in thousands):
 Fiscal Year Ended
 202120222023
United States$1,195,428 $1,580,022 $1,971,757 
Rest of the world488,751 600,826 781,677 
Total revenue$1,684,179 $2,180,848 $2,753,434 
Schedule of Long-Lived Assets by Geographic Area
Long-lived assets, which are comprised of property and equipment, net, by geographic area are summarized as follows (in thousands):
 At the End of Fiscal
 20222023
United States$187,228 $259,131 
Rest of the world8,054 13,314 
Total long-lived assets$195,282 $272,445 
v3.23.1
Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details)
3 Months Ended 12 Months Ended
Feb. 07, 2022
USD ($)
May 02, 2021
Feb. 05, 2023
USD ($)
financialInstitution
revenueSource
Feb. 06, 2022
USD ($)
Jan. 31, 2021
USD ($)
Concentration Risk [Line Items]          
Number of financial institutions where deposits exceed federally insured limits | financialInstitution     2    
Restricted cash     $ 10,544,000 $ 10,544,000 $ 10,544,000
Depreciation and amortization     $ 100,432,000 83,151,000 70,042,000
Useful life of deferred commissions related to subscription services revenue     6 years    
Number of revenue sources | revenueSource     2    
Warranty reserve     $ 7,400,000    
Capitalized software, amortization     1,500,000 500,000 100,000
Advertising expenses     11,100,000 15,300,000 8,100,000
Reduce in additional paid-in capital $ 133,300,000        
Debt instrument increase net 35,200,000        
Accumulated deficit $ 98,100,000   1,537,062,000 1,708,271,000  
Property, Plant and Equipment          
Concentration Risk [Line Items]          
Software development costs capitalized during the period     7,300,000 7,800,000  
Capitalized software, amortization     2,200,000 0 0
Other Assets          
Concentration Risk [Line Items]          
Software development costs capitalized during the period     $ 9,300,000 $ 3,500,000  
Hardware          
Concentration Risk [Line Items]          
Standard product warranty period     3 years    
Embedded Software          
Concentration Risk [Line Items]          
Standard product warranty period     90 days    
Change in accounting estimate          
Concentration Risk [Line Items]          
Depreciation and amortization         $ (23,600,000)
Minimum          
Concentration Risk [Line Items]          
Estimated useful life of intangible assets     3 years    
Maximum          
Concentration Risk [Line Items]          
Estimated useful life of intangible assets     7 years    
Test equipment          
Concentration Risk [Line Items]          
Property and equipment, useful life     4 years    
Computer equipment and software | Minimum          
Concentration Risk [Line Items]          
Property and equipment, useful life   2 years 4 years    
Computer equipment and software | Maximum          
Concentration Risk [Line Items]          
Property and equipment, useful life   3 years 5 years    
Furniture and fixtures          
Concentration Risk [Line Items]          
Property and equipment, useful life     7 years    
Test equipment, certain computer equipment and software          
Concentration Risk [Line Items]          
Property and equipment, useful life   4 years      
Software development costs          
Concentration Risk [Line Items]          
Property and equipment, useful life     4 years    
Customer concentration risk | Accounts receivable | 1 Channel Partner          
Concentration Risk [Line Items]          
Concentration risk percentage       1000.00%  
Customer concentration risk | Accounts receivable | No Channel Partner or Customer          
Concentration Risk [Line Items]          
Concentration risk percentage     1000.00%    
Customer concentration risk | Revenue | No Channel Partner or Customer          
Concentration Risk [Line Items]          
Concentration risk percentage     1000.00% 1000.00% 1000.00%
v3.23.1
Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Changes in Allowance for Doubtful Accounts (Details) - USD ($)
$ in Thousands
12 Months Ended
Feb. 05, 2023
Feb. 06, 2022
Jan. 31, 2021
Allowance for Doubtful Accounts Receivable [Roll Forward]      
Allowance for doubtful accounts, beginning balance $ 945 $ 1,033 $ 542
Provision, net of cash received 377 (18) 496
Write-offs (265) (70) (5)
Allowance for doubtful accounts, ending balance $ 1,057 $ 945 $ 1,033
v3.23.1
Basis of Presentation and Summary of Significant Accounting Policies - Revenue Recognition (Details) - Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-02-06
Feb. 05, 2023
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Revenue contractual term 12 months
Subscription Service Revenue | Minimum  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Revenue contractual term 1 year
Subscription Service Revenue | Maximum  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Revenue contractual term 6 years
v3.23.1
Financial Instruments - Cash Equivalents, Marketable Securities and Restricted Cash (Details) - USD ($)
$ in Thousands
Feb. 05, 2023
Feb. 06, 2022
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost $ 1,015,046  
Fair Value 1,001,352  
Cash Equivalents 71,197 $ 18,931
Marketable securities 1,001,352 947,073
Restricted Cash 10,544 10,544
Amortized Cost 1,047,054 953,828
Total gross unrealized gains 1,352 1,093
Total gross unrealized losses (15,046) (7,648)
Total fair value 1,083,093 976,548
Level 1 | Money market accounts    
Debt Securities, Available-for-sale [Line Items]    
Fair Value 49,733 29,275
Cash Equivalents 39,189 18,731
Marketable securities 0 0
Restricted Cash 10,544 10,544
Level 2 | U.S. government treasury notes    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 425,977 336,303
Gross Unrealized Gains 170 512
Gross Unrealized Losses (4,229) (2,176)
Fair Value 421,918 334,639
Cash Equivalents 32,008 0
Marketable securities 389,910 334,639
Restricted Cash 0 0
Level 2 | U.S. government agencies    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 23,795 49,153
Gross Unrealized Gains 0 49
Gross Unrealized Losses (289) (193)
Fair Value 23,506 49,009
Cash Equivalents 0 0
Marketable securities 23,506 49,009
Restricted Cash 0 0
Level 2 | Corporate debt securities    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 527,164 491,728
Gross Unrealized Gains 901 384
Gross Unrealized Losses (9,300) (4,731)
Fair Value 518,765 487,381
Cash Equivalents 0 200
Marketable securities 518,765 487,181
Restricted Cash 0 0
Level 2 | Foreign government bonds    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 4,797 12,333
Gross Unrealized Gains 0 37
Gross Unrealized Losses (44) (17)
Fair Value 4,753 12,353
Cash Equivalents 0 0
Marketable securities 4,753 12,353
Restricted Cash 0 0
Level 2 | Asset-backed securities    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 61,371 60,361
Gross Unrealized Gains 281 111
Gross Unrealized Losses (1,016) (453)
Fair Value 60,636 60,019
Cash Equivalents 0 0
Marketable securities 60,636 60,019
Restricted Cash 0 0
Level 2 | Municipal bonds    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 3,950 3,950
Gross Unrealized Gains 0 0
Gross Unrealized Losses (168) (78)
Fair Value 3,782 3,872
Cash Equivalents 0 0
Marketable securities 3,782 3,872
Restricted Cash $ 0 $ 0
v3.23.1
Financial Instruments - Amortized Cost and Estimated Fair Value (Details) - USD ($)
12 Months Ended
Feb. 05, 2023
Feb. 06, 2022
Jan. 31, 2021
Amortized Cost      
Due within one year $ 542,675,000    
Due in one to five years 468,427,000    
Due in five to ten years 3,944,000    
Amortized Cost 1,015,046,000    
Fair Value      
Due within one year 537,272,000    
Due in one to five years 460,091,000    
Due in five to ten years 3,989,000    
Total 1,001,352,000    
Impairment charge for unrealized losses $ 0 $ 0 $ 0
v3.23.1
Financial Instruments - Gross Unrealized Losses and Fair Values (Details) - USD ($)
$ in Thousands
Feb. 05, 2023
Feb. 06, 2022
Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract]    
Fair Value, Less then 12 months $ 360,946 $ 637,548
Unrealized Loss, Less then 12 months (495) (7,625)
Fair Value Greater then 12 months 450,559 1,182
Unrealized Loss, Greater then 12 months (14,551) (23)
Fair Value Total 811,505 638,730
Unrealized Loss Total (15,046) (7,648)
U.S. government treasury notes    
Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract]    
Fair Value, Less then 12 months 250,046 193,359
Unrealized Loss, Less then 12 months (130) (2,176)
Fair Value Greater then 12 months 127,976 0
Unrealized Loss, Greater then 12 months (4,099) 0
Fair Value Total 378,022 193,359
Unrealized Loss Total (4,229) (2,176)
U.S. government agencies    
Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract]    
Fair Value, Less then 12 months 5,194 24,388
Unrealized Loss, Less then 12 months (5) (193)
Fair Value Greater then 12 months 18,312 0
Unrealized Loss, Greater then 12 months (284) 0
Fair Value Total 23,506 24,388
Unrealized Loss Total (289) (193)
Corporate debt securities    
Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract]    
Fair Value, Less then 12 months 99,446 374,223
Unrealized Loss, Less then 12 months (330) (4,708)
Fair Value Greater then 12 months 277,717 1,182
Unrealized Loss, Greater then 12 months (8,970) (23)
Fair Value Total 377,163 375,405
Unrealized Loss Total (9,300) (4,731)
Foreign government bonds    
Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract]    
Fair Value, Less then 12 months 3,200 4,098
Unrealized Loss, Less then 12 months (5) (17)
Fair Value Greater then 12 months 551 0
Unrealized Loss, Greater then 12 months (39) 0
Fair Value Total 3,751 4,098
Unrealized Loss Total (44) (17)
Asset-backed securities    
Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract]    
Fair Value, Less then 12 months 3,060 37,608
Unrealized Loss, Less then 12 months (25) (453)
Fair Value Greater then 12 months 22,221 0
Unrealized Loss, Greater then 12 months (991) 0
Fair Value Total 25,281 37,608
Unrealized Loss Total (1,016) (453)
Municipal bonds    
Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract]    
Fair Value, Less then 12 months 0 3,872
Unrealized Loss, Less then 12 months 0 (78)
Fair Value Greater then 12 months 3,782 0
Unrealized Loss, Greater then 12 months (168) 0
Fair Value Total 3,782 3,872
Unrealized Loss Total $ (168) $ (78)
v3.23.1
Business Combination - Additional Information (Details) - Portworx - USD ($)
shares in Millions
1 Months Ended
Oct. 31, 2020
Feb. 05, 2023
Jan. 31, 2021
Business Acquisition [Line Items]      
Total purchase consideration $ 352,851,000    
Goodwill expected to be tax deductible 0    
Deferred tax assets, before valuation allowance 14,700,000    
Deferred tax assets, valuation allowance 14,700,000    
Deferred tax assets, net     $ 0
Transaction price contingent on continuous employment of founders $ 32,200,000 $ 4,900,000  
Transaction price contingent on continuous employment of founders, earnout period 3 years    
Replacement Awards      
Business Acquisition [Line Items]      
Shares issued upon conversion of stock options (in shares) 1.9    
Equity interests issued and issuable $ 26,800,000    
Replacement Awards for Services Performed Prior to the Acquisition      
Business Acquisition [Line Items]      
Equity interests issued and issuable 8,800,000    
Replacement Awards for Future Services      
Business Acquisition [Line Items]      
Equity interests issued and issuable 18,000,000    
Unvested RSUs and PRSUs      
Business Acquisition [Line Items]      
Equity interests issued and issuable $ 31,800,000    
Outstanding awards assumed (in shares) 2.0    
Equity awards vesting period 4 years    
v3.23.1
Business Combination - Purchase Consideration (Details) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Oct. 31, 2020
Feb. 05, 2023
Feb. 06, 2022
Jan. 31, 2021
Business Acquisition [Line Items]        
Fair value of options assumed   $ 0 $ 0 $ 8,802
Portworx        
Business Acquisition [Line Items]        
Cash $ 344,049      
Fair value of options assumed 8,802      
Total $ 352,851      
v3.23.1
Business Combination - Net Assets Acquired (Details) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Oct. 31, 2020
Feb. 05, 2023
Feb. 06, 2022
Business Acquisition [Line Items]      
Goodwill   $ 361,427 $ 358,736
Developed technology      
Business Acquisition [Line Items]      
Estimated Useful Life   3 years  
Customer relationships      
Business Acquisition [Line Items]      
Estimated Useful Life   4 years 8 months 12 days  
Trade name      
Business Acquisition [Line Items]      
Estimated Useful Life   7 months 6 days  
Portworx      
Business Acquisition [Line Items]      
Goodwill $ 321,152    
Cash 4,407    
Net liabilities assumed (4,063)    
Total 352,851    
Portworx | Developed technology      
Business Acquisition [Line Items]      
Identified intangible assets: $ 21,273    
Estimated Useful Life 5 years    
Portworx | Customer relationships      
Business Acquisition [Line Items]      
Identified intangible assets: $ 6,459    
Estimated Useful Life 7 years    
Portworx | Trade name      
Business Acquisition [Line Items]      
Identified intangible assets: $ 3,623    
Estimated Useful Life 3 years    
v3.23.1
Balance Sheet Components - Inventory (Details) - USD ($)
$ in Thousands
Feb. 05, 2023
Feb. 06, 2022
Balance Sheet Components Disclosure [Abstract]    
Raw materials $ 24,896 $ 15,734
Finished goods 25,256 23,208
Inventory $ 50,152 $ 38,942
v3.23.1
Balance Sheet Components - Property and Equipment, Net (Details) - USD ($)
$ in Thousands
Feb. 05, 2023
Feb. 06, 2022
Property Plant And Equipment [Line Items]    
Total property and equipment $ 674,598 $ 537,348
Less: accumulated depreciation and amortization (402,153) (342,066)
Property and equipment, net 272,445 195,282
Test equipment    
Property Plant And Equipment [Line Items]    
Total property and equipment 315,290 266,672
Computer equipment and software    
Property Plant And Equipment [Line Items]    
Total property and equipment 262,574 206,053
Furniture and fixtures    
Property Plant And Equipment [Line Items]    
Total property and equipment 9,693 8,652
Leasehold improvements    
Property Plant And Equipment [Line Items]    
Total property and equipment 71,235 47,443
Capitalized software development costs    
Property Plant And Equipment [Line Items]    
Total property and equipment $ 15,806 $ 8,528
v3.23.1
Balance Sheet Components - Additional Information (Details) - USD ($)
$ in Millions
12 Months Ended
Feb. 05, 2023
Feb. 06, 2022
Jan. 31, 2021
Finite Lived Intangible Assets [Line Items]      
Depreciation and amortization $ 87.0 $ 65.9 $ 57.1
Intangible assets amortization expense $ 16.5 $ 16.8 $ 13.0
Technology patents      
Finite Lived Intangible Assets [Line Items]      
Estimated Useful Life 1 year 7 months 6 days    
Developed technology      
Finite Lived Intangible Assets [Line Items]      
Estimated Useful Life 3 years    
Customer relationships      
Finite Lived Intangible Assets [Line Items]      
Estimated Useful Life 4 years 8 months 12 days    
Trade name      
Finite Lived Intangible Assets [Line Items]      
Estimated Useful Life 7 months 6 days    
v3.23.1
Balance Sheet Components - Intangible Assets, Net (Details) - USD ($)
$ in Thousands
Feb. 05, 2023
Feb. 06, 2022
Finite Lived Intangible Assets [Line Items]    
Gross Carrying Value $ 112,418 $ 109,373
Accumulated Amortization (63,196) (46,727)
Net Carrying Amount 49,222 62,646
Technology patents    
Finite Lived Intangible Assets [Line Items]    
Gross Carrying Value 19,125 19,125
Accumulated Amortization (14,826) (13,544)
Net Carrying Amount 4,299 5,581
Developed technology    
Finite Lived Intangible Assets [Line Items]    
Gross Carrying Value 83,211 80,166
Accumulated Amortization (43,366) (30,304)
Net Carrying Amount 39,845 49,862
Customer relationships    
Finite Lived Intangible Assets [Line Items]    
Gross Carrying Value 6,459 6,459
Accumulated Amortization (2,166) (1,246)
Net Carrying Amount 4,293 5,213
Trade name    
Finite Lived Intangible Assets [Line Items]    
Gross Carrying Value 3,623 3,623
Accumulated Amortization (2,838) (1,633)
Net Carrying Amount $ 785 $ 1,990
v3.23.1
Balance Sheet Components - Expected Amortization Expenses for Intangible Assets (Details) - USD ($)
$ in Thousands
Feb. 05, 2023
Feb. 06, 2022
Balance Sheet Components Disclosure [Abstract]    
2024 $ 16,210  
2025 15,425  
2026 12,830  
2027 3,107  
2028 1,054  
Thereafter 596  
Net Carrying Amount $ 49,222 $ 62,646
v3.23.1
Balance Sheet Components - Goodwill (Details) - USD ($)
12 Months Ended
Feb. 05, 2023
Feb. 06, 2022
Goodwill    
Goodwill, beginning balance $ 358,736,000  
Goodwill acquired 2,691,000  
Goodwill, ending balance 361,427,000 $ 358,736,000
Impairment of goodwill $ 0 $ 0
v3.23.1
Balance Sheet Components - Schedule of Accrued Expenses and Other Liabilities (Details) - USD ($)
$ in Thousands
Feb. 05, 2023
Feb. 06, 2022
Balance Sheet Components Disclosure [Abstract]    
Taxes payable $ 16,615 $ 6,312
Accrued marketing 14,228 13,257
Accrued cloud and outside services 7,644 6,135
Supply chain-related accruals 23,545 6,991
Accrued service logistics and professional services 7,927 6,244
Acquisition earn-out and deferred consideration 3,556 5,211
Finance lease liabilities, current 5,432 1,035
Customer deposits from contracts with customers 17,824 10,409
Other accrued liabilities 26,978 22,917
Accrued expenses and other liabilities $ 123,749 $ 78,511
v3.23.1
Deferred Revenue and Commissions - Deferred Commissions (Details) - USD ($)
12 Months Ended
Feb. 05, 2023
Feb. 06, 2022
Jan. 31, 2021
Deferred Commissions [Roll Forward]      
Beginning balance $ 246,307,000 $ 187,924,000  
Additions 155,414,000 217,595,000  
Recognition of deferred commissions (155,865,000) (159,212,000)  
Ending balance 245,856,000 246,307,000 $ 187,924,000
Sales commission expenses $ 170,000,000 175,900,000 150,200,000
Commission expected to be recognized over the next 12 months (percent) 28.00%    
Impairment of capitalized commissions $ 0 $ 0 $ 0
v3.23.1
Deferred Revenue and Commissions - Deferred Revenue (Details) - USD ($)
$ in Thousands
12 Months Ended
Feb. 05, 2023
Feb. 06, 2022
Contract Liability    
Additions $ 155,414 $ 217,595
Recognition of deferred commissions (155,865) (159,212)
Revenue pertaining to deferred revenue recognized in period 567,800 442,700
Product Revenue and Support Subscription Revenue    
Contract Liability    
Beginning balance 1,079,872 843,697
Additions 1,248,417 937,510
Recognition of deferred commissions (942,639) (701,335)
Ending balance $ 1,385,650 $ 1,079,872
v3.23.1
Deferred Revenue and Commissions - Remaining Performance Obligations (Details)
$ in Billions
Feb. 05, 2023
USD ($)
Revenue from Contract with Customer [Abstract]  
Contracted but not recognized revenue $ 1.8
Performance obligation expected to be recognized as revenue in the next 12 months (percent) 47.00%
v3.23.1
Deferred Revenue and Commissions - Remaining Performance Obligation Period (Details)
Feb. 05, 2023
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-02-06  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Revenue expected to be recognized term (in months) 12 months
v3.23.1
Debt - Additional Information (Details)
1 Months Ended 3 Months Ended 12 Months Ended
Aug. 24, 2020
USD ($)
financial_ratio
Mar. 31, 2023
Feb. 28, 2022
USD ($)
Apr. 30, 2018
USD ($)
shares
$ / shares
May 08, 2022
USD ($)
Feb. 05, 2023
USD ($)
$ / shares
Feb. 06, 2022
USD ($)
Jan. 31, 2021
USD ($)
Apr. 04, 2018
$ / shares
Debt Instrument [Line Items]                  
Proceeds from issuance of convertible debt           $ 0 $ 0 $ 251,892,000  
Closing price of stock (in dollars per share) | $ / shares           $ 29.91      
Revolving Credit Facility                  
Debt Instrument [Line Items]                  
Debt instrument, term 5 years                
Senior secured credit facility, maximum borrowing capacity $ 300,000,000                
Credit facility, maturity period prior to stated maturity if out of compliance with liquidity threshold 91 days                
Credit facility, daily minimum sum of cash and cash equivalents and aggregate unused commitments to prevent maturity prior to stated maturity $ 625,000,000                
Repayments of lines of credit     $ 250,000,000            
Interest rate during the period (percent)         1.61%   1.60% 1.65%  
Interest expense         $ 300,000   $ 4,100,000 $ 1,400,000  
Number of financial ratios | financial_ratio 2                
Consolidated leverage ratio, maximum           4.5      
Interest coverage ratio, minimum           3      
Revolving Credit Facility | London Interbank Offered Rate (LIBOR) | Interest Rate Floor                  
Debt Instrument [Line Items]                  
Effective interest rate (percent) 0.00%                
Revolving Credit Facility | London Interbank Offered Rate (LIBOR) | Interest Rate Floor | Subsequent Event                  
Debt Instrument [Line Items]                  
Effective interest rate (percent)   0.00%              
Revolving Credit Facility | Minimum                  
Debt Instrument [Line Items]                  
Commitment fee (percent) 0.25%                
Revolving Credit Facility | Minimum | Base Rate                  
Debt Instrument [Line Items]                  
Margin rate (percent) 0.50%                
Revolving Credit Facility | Minimum | London Interbank Offered Rate (LIBOR)                  
Debt Instrument [Line Items]                  
Margin rate (percent) 1.50%                
Revolving Credit Facility | Minimum | London Interbank Offered Rate (LIBOR) | Subsequent Event                  
Debt Instrument [Line Items]                  
Margin rate (percent)   1.50%              
Revolving Credit Facility | Maximum                  
Debt Instrument [Line Items]                  
Commitment fee (percent) 0.40%                
Revolving Credit Facility | Maximum | Base Rate                  
Debt Instrument [Line Items]                  
Margin rate (percent) 1.25%                
Revolving Credit Facility | Maximum | London Interbank Offered Rate (LIBOR)                  
Debt Instrument [Line Items]                  
Margin rate (percent) 2.25%                
Revolving Credit Facility | Maximum | London Interbank Offered Rate (LIBOR) | Subsequent Event                  
Debt Instrument [Line Items]                  
Margin rate (percent)   2.25%              
Capped Call                  
Debt Instrument [Line Items]                  
Payment to enter into agreement       $ 64,600,000          
Common stock                  
Debt Instrument [Line Items]                  
Closing price of stock (in dollars per share) | $ / shares           $ 29.91      
Common stock | Capped Call                  
Debt Instrument [Line Items]                  
Exercise price (in dollars per share) | $ / shares                 $ 39.66
Exercise price premium percentage over last reported sales price                 100.00%
Convertible Senior Notes                  
Debt Instrument [Line Items]                  
Principal amount       $ 575,000,000          
Interest rate ( as a percent)       0.125%          
Proceeds from issuance of convertible debt       $ 562,100,000          
Conversion percentage of principal amount plus accrued and unpaid contingent interest       100.00%          
Convertible debt, fair value based on the closing trading price per $100 of the Notes           $ 660,000,000 681,800,000    
If-converted value           $ 654,600,000      
Remaining term of the notes           2 months      
Interest expense           $ 3,314,000 $ 31,697,000    
Convertible Senior Notes | Common stock                  
Debt Instrument [Line Items]                  
Number of convertible shares at initial conversion rate (in shares) | shares       21,884,155          
Conversion ratio (in shares per $1,000 principal amount)       0.0380594          
Conversion price (in dollars per share) | $ / shares       $ 26.27          
v3.23.1
Debt - Convertible Debt (Details) - USD ($)
$ in Thousands
12 Months Ended
Feb. 05, 2023
Feb. 06, 2022
Convertible Senior Notes    
Liability:    
Principal $ 575,000 $ 575,000
Less: debt discount, net of amortization 0 (35,641)
Less: debt issuance costs, net of amortization (494) (2,580)
Net carrying amount of the Notes 574,506 536,779
Additional Paid-In Capital    
Stockholders' equity recorded at issuance:    
Allocated value of the conversion feature   136,333
Less: debt issuance costs 0 (3,068)
Additional paid-in capital $ 0 $ 133,265
v3.23.1
Debt - Interest Expense (Details) - USD ($)
$ in Thousands
12 Months Ended
Feb. 05, 2023
Feb. 06, 2022
Jan. 31, 2021
Debt Instrument [Line Items]      
Total amortization of debt discount and debt issuance costs $ 3,210 $ 31,577 $ 29,070
Convertible Senior Notes      
Debt Instrument [Line Items]      
Amortization of debt discount 0 28,874  
Amortization of debt issuance costs 2,598 2,091  
Total amortization of debt discount and debt issuance costs 2,598 30,965  
Contractual interest expense 716 732  
Total interest expense related to the Notes $ 3,314 $ 31,697  
Effective interest rate of the liability component ( as a percent) 0.60% 5.60%  
v3.23.1
Commitments and Contingencies - (Details) - USD ($)
Feb. 05, 2023
Feb. 06, 2022
Commitments and Contingencies Disclosure [Abstract]    
Non-cancelable purchase obligations $ 445,000,000  
Outstanding letters of credit 8,000,000 $ 6,700,000
Loss contingency $ 0  
v3.23.1
Leases - Additional Information (Details) - USD ($)
$ in Thousands
1 Months Ended
Jun. 30, 2022
May 31, 2024
Feb. 05, 2023
Aug. 31, 2022
Feb. 06, 2022
Lessee, Lease, Description [Line Items]          
Sublease term 8 years        
Total lease payments that include rent escalation and abatement clauses $ 100,200   $ 214,554 $ 89,400  
Weighted-average remaining lease term (in years)     5 years 2 months 12 days   4 years 6 months
Weighted-average discount rate     6.10%   5.70%
Forecast          
Lessee, Lease, Description [Line Items]          
Total lease payments that include rent escalation and abatement clauses   $ 10,800      
v3.23.1
Leases - Lease Costs (Details) - USD ($)
$ in Thousands
12 Months Ended
Feb. 05, 2023
Feb. 06, 2022
Jan. 31, 2021
Leases [Abstract]      
Fixed operating lease cost $ 47,533 $ 37,598 $ 37,411
Variable lease cost 8,521 10,228 9,168
Short-term lease cost (12 months or less) 3,787 4,178 5,734
Amortization of finance lease right-of-use assets 3,028 384 0
Interest on finance lease liabilities 330 42 0
Total finance lease cost 3,358 426 0
Total lease cost $ 63,199 $ 52,430 $ 52,313
v3.23.1
Leases - Lease Term and Discount Rate (Details) - USD ($)
$ in Thousands
Feb. 05, 2023
Feb. 06, 2022
Operating leases:    
Weighted-average remaining lease term (in years) 5 years 2 months 12 days 4 years 6 months
Weighted-average discount rate 6.10% 5.70%
Finance leases:    
Finance lease right-of-use assets, gross $ 17,596 $ 3,577
Accumulated amortization (3,412) (384)
Finance lease right-of-use assets, net 14,184 3,193
Finance lease liabilities, current 5,432 1,035
Finance lease liabilities, non-current 4,765 1,487
Total finance lease liabilities $ 10,197 $ 2,522
Weighted-average remaining lease term (in years) 3 years 3 months 18 days 3 years 7 months 6 days
Weighted-average discount rate 5.10% 2.70%
Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration] Other liabilities, non-current, Accrued expenses and other liabilities Other liabilities, non-current, Accrued expenses and other liabilities
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Accrued expenses and other liabilities Accrued expenses and other liabilities
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Other liabilities, non-current Other liabilities, non-current
v3.23.1
Leases - Supplemental Cash Flow Information Related to Leases (Details) - USD ($)
$ in Thousands
12 Months Ended
Feb. 05, 2023
Feb. 06, 2022
Leases [Abstract]    
Operating cash outflows for operating leases $ 49,955 $ 36,648
Financing cash outflows for finance leases 6,138 1,000
Operating leases 80,962 7,517
Finance leases $ 14,019 $ 3,577
v3.23.1
Leases - Future Lease Payments Under Non-Cancelable Leases (Details) - USD ($)
$ in Thousands
Feb. 05, 2023
Aug. 31, 2022
Jun. 30, 2022
Feb. 06, 2022
Operating Leases        
2024 $ 45,153      
2025 48,315      
2026 36,366      
2027 19,384      
2028 21,062      
Thereafter 44,274      
Total future lease payments 214,554 $ 89,400 $ 100,200  
Less: imputed interest (38,374)      
Present value of total lease liabilities 176,180      
Finance Leases        
2024 5,839      
2025 4,728      
2026 183      
2027 0      
2028 0      
Thereafter 0      
Total future lease payments 10,750      
Less: imputed interest (553)      
Present value of total lease liabilities $ 10,197     $ 2,522
v3.23.1
Restructuring and Other (Details) - USD ($)
$ in Thousands
12 Months Ended
Jan. 31, 2021
Feb. 05, 2023
Restructuring Cost and Reserve [Line Items]    
Lease liabilities   $ 176,180
COVID-19 Pandemic Costs    
Restructuring Cost and Reserve [Line Items]    
Restructuring and other $ 9,800  
COVID-19 Pandemic Costs | Restructuring Charges    
Restructuring Cost and Reserve [Line Items]    
Restructuring and other 8,900  
COVID-19 Pandemic Costs | Cost of Revenue    
Restructuring Cost and Reserve [Line Items]    
Restructuring and other 900  
Ceased Use of Certain Leased Facilities    
Restructuring Cost and Reserve [Line Items]    
Impairment charge 7,500  
Lease liabilities 2,400  
One-time Involuntary Termination Benefits | Restructuring Charges    
Restructuring Cost and Reserve [Line Items]    
Restructuring and other $ 12,200  
v3.23.1
Stockholders' Equity - Additional Information (Details)
2 Months Ended 12 Months Ended
Mar. 31, 2023
USD ($)
Feb. 05, 2023
USD ($)
stock_class
$ / shares
shares
Feb. 06, 2022
USD ($)
$ / shares
shares
Jan. 31, 2021
USD ($)
$ / shares
shares
Mar. 31, 2022
USD ($)
Feb. 28, 2021
USD ($)
Aug. 31, 2019
USD ($)
Class of Stock [Line Items]              
Preferred stock, shares authorized (in shares)   20,000,000 20,000,000        
Preferred stock, shares issued (in shares)   0 0        
Preferred stock, shares outstanding (in shares)   0 0        
Number of classes of stock | stock_class   2          
Common stock, shares authorized (in shares)   2,250,000,000 2,250,000,000        
Board of Directors              
Class of Stock [Line Items]              
Value approved for repurchase | $         $ 250,000,000    
Remaining authorized repurchase amount | $   $ 31,100,000          
Board of Directors | Subsequent Event              
Class of Stock [Line Items]              
Additional value approved for repurchase | $ $ 250,000,000            
Class A common stock              
Class of Stock [Line Items]              
Common stock, shares authorized (in shares)   2,000,000,000 2,000,000,000        
Common stock, par value per share (in dollars per share) | $ / shares   $ 0.0001 $ 0.0001        
Common stock, shares issued (in shares)   304,076,234 292,633,000        
Common stock, shares outstanding (in shares)   304,076,234 292,633,000        
Stock repurchased and retired (in shares)   7,832,229 8,489,168 9,526,556      
Stock repurchased and retired, average cost (in dollars per share) | $ / shares   $ 27.95 $ 23.56 $ 14.17      
Stock repurchased and retired, value | $   $ 218,900,000 $ 200,000,000 $ 135,000,000      
Class A common stock | Subsequent Event              
Class of Stock [Line Items]              
Stock repurchased and retired, value | $ $ 31,100,000            
Class A common stock | Board of Directors              
Class of Stock [Line Items]              
Value approved for repurchase | $           $ 200,000,000 $ 150,000,000
Class B common stock              
Class of Stock [Line Items]              
Common stock, shares authorized (in shares)   250,000,000 250,000,000        
Common stock, par value per share (in dollars per share) | $ / shares   $ 0.0001 $ 0.0001        
v3.23.1
Stockholders' Equity - Summary of Reserved Shares of Common Stock for Future Issuance (Details) - shares
Feb. 05, 2023
Feb. 06, 2022
Class of Stock [Line Items]    
Shares underlying outstanding equity awards (in shares) 9,268,498 12,268,938
Shares reserved for future equity awards (in shares) 62,000,412  
Employee stock purchase plan    
Class of Stock [Line Items]    
Shares reserved for future equity awards (in shares) 5,309,812  
Unvested RSUs and PRSUs    
Class of Stock [Line Items]    
Shares underlying outstanding equity awards (in shares) 26,760,520  
Employee Stock Options    
Class of Stock [Line Items]    
Shares reserved for future equity awards (in shares) 20,661,582  
v3.23.1
Equity Incentive Plans - Additional Information (Details)
12 Months Ended
Feb. 05, 2023
USD ($)
period
plan
$ / shares
shares
Feb. 06, 2022
USD ($)
Jan. 31, 2021
USD ($)
shares
Jan. 31, 2016
shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Number of equity incentive plans | plan 2      
Shares reserved for future equity awards (in shares) | shares 62,000,412      
Total stock-based compensation expense $ 327,617,000 $ 286,963,000 $ 242,344,000  
Closing price of stock (in dollars per share) | $ / shares $ 29.91      
Stock options to purchase common stock        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Shares reserved for future equity awards (in shares) | shares 20,661,582      
Total stock-based compensation expense $ 4,900,000 7,700,000 8,600,000  
Unrecognized compensation cost related to stock awards, weighted-average period 1 year 1 month 6 days      
Intrinsic value of exercised options $ 63,500,000 105,100,000 118,800,000  
Total grant date fair value of options vested 7,000,000 $ 16,500,000 $ 20,100,000  
Unrecognized compensation cost $ 2,400,000      
Dividend rate     0.00%  
Employee Stock Purchase Plan        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Dividend rate 0.00% 0.00% 0.00%  
Performance Restricted Stock Units (PRSUs)        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Granted (in shares) | shares 1,147,187      
Award vesting rights, percentage 100.00%      
Earned (in shares) | shares 1,770,282      
Unvested RSUs and PRSUs        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Total stock-based compensation expense $ 299,700,000 $ 242,100,000 $ 199,100,000  
Unrecognized compensation cost related to stock awards, weighted-average period 2 years 8 months 12 days      
Granted (in shares) | shares 15,319,768      
Aggregate fair value of awards vested during the period $ 402,700,000 322,200,000 183,400,000  
Unrecognized employee compensation cost 588,400,000      
Unvested restricted stock        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Total stock-based compensation expense 0 1,800,000 9,300,000  
Aggregate fair value of awards vested during the period $ 1,900,000 10,400,000 $ 18,300,000  
Minimum | Performance Restricted Stock Units (PRSUs)        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Award vesting rights, percentage 0.00%      
Maximum | Performance Restricted Stock Units (PRSUs)        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Award vesting rights, percentage 150.00%      
Common stock        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Closing price of stock (in dollars per share) | $ / shares $ 29.91      
2015 Equity Incentive Plan        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Equity awards of vest expire period 10 years      
2015 Equity Incentive Plan | Minimum        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Equity awards vesting period 2 years      
2015 Equity Incentive Plan | Maximum        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Equity awards vesting period 4 years      
2015 Equity Incentive Plan | Common stock        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Shares initially reserved for issuance (in shares) | shares 27,000,000      
Equity incentive plan, period in force 10 years      
Increase in shares reserved by percentage of capital stock 5.00%      
2015 Employee Stock Purchase Plan        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Shares reserved for future equity awards (in shares) | shares     5,000,000  
Employee stock purchase plan offering period 24 months      
Number of purchase periods | period 4      
Purchase period, term 6 months      
ESPP modification charge $ 10,400,000 0 $ 23,800,000  
Total stock-based compensation expense 22,900,000 35,400,000 $ 25,800,000  
Unrecognized stock-based compensation expense $ 31,500,000      
Unrecognized compensation cost related to stock awards, weighted-average period 1 year 7 months 6 days      
2015 Employee Stock Purchase Plan | Common stock        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Increase in shares reserved by percentage of capital stock 1.00%      
Shares reserved for future equity awards (in shares) | shares       3,500,000
Maximum annual increase to shares reserved for issuance under the Plan | shares 3,500,000      
Payroll deductions percentage 30.00%      
Share cap for ESPP at purchase date (in shares) | shares 3,000      
Dollar cap per purchase period $ 7,500      
Calendar year gap for ESPP contribution amount   $ 25,000    
Purchase price as percentage of fair market value of common stock 85.00%      
v3.23.1
Equity Incentive Plans - Equity Incentive Plans (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Feb. 05, 2023
Feb. 06, 2022
Options Outstanding, Number of Shares    
Beginning balance (in shares) 12,268,938  
Options exercised (in shares) (2,988,068)  
Options forfeited (in shares) (12,372)  
Ending balance (in shares) 9,268,498 12,268,938
Vested and exercisable (in shares) 9,077,014  
Options Outstanding, Weighted- Average Exercise Price    
Beginning balance (in dollars per share) $ 10.25  
Options exercised (in dollars per share) 8.29  
Options forfeited (in dollars per share) 1.83  
Ending balance (in dollars per share) 10.90 $ 10.25
Vested and exercisable (in dollars per share) $ 11.04  
Weighted- Average Remaining Contractual Life (Years)    
Weighted Average Remaining Contractual Life (Years) 2 years 8 months 12 days 3 years 6 months
Weighted Average Remaining Contractual Life (Years), Vested and exercisable 2 years 7 months 6 days  
Aggregate Intrinsic Value (in thousands)    
Aggregate Intrinsic Value $ 176,674 $ 198,266
Aggregate Intrinsic Value, Vested and exercisable $ 171,315  
v3.23.1
Equity Incentive Plans - Summary of Estimate Fair Values (Details) - $ / shares
12 Months Ended
Feb. 05, 2023
Feb. 06, 2022
Jan. 31, 2021
Employee Stock Options      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Expected term (in years)     5 years 7 months 24 days
Expected volatility     52.07%
Risk-free interest rate     0.30%
Dividend rate     0.00%
Fair value of common stock (in dollars per share)     $ 15.79
Employee Stock Purchase Plan      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Dividend rate 0.00% 0.00% 0.00%
Expected volatility, minimum 45.00% 44.00% 52.00%
Expected volatility, maximum 54.00% 61.00% 113.00%
Risk-free interest rate, minimum 0.90% 0.10% 0.10%
Risk-free interest rate, maximum 4.00% 0.20% 0.40%
Employee Stock Purchase Plan | Minimum      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Expected term (in years) 6 months 6 months 6 months
Fair value of common stock (in dollars per share) $ 28.73 $ 23.63 $ 9.07
Employee Stock Purchase Plan | Maximum      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Expected term (in years) 2 years 2 years 2 years
Fair value of common stock (in dollars per share) $ 31.68 $ 26.69 $ 15.26
v3.23.1
Equity Incentive Plans - Restricted Stock Units (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Feb. 05, 2023
Feb. 06, 2022
Unvested RSUs and PRSUs    
Number of RSUs and PRSUs Outstanding    
Unvested, beginning balance (in shares) 28,712,878  
Granted (in shares) 15,319,768  
Vested (in shares) (13,915,802)  
Forfeited (in shares) (3,356,324)  
Unvested, ending balance (in shares) 26,760,520  
Weighted-Average Grant Date Fair Value    
Unvested, beginning balance (in dollars per share) $ 19.53  
Granted (in dollars per share) 29.67  
Vested (in dollars per share) 20.05  
Forfeited (in dollars per share) 21.75  
Unvested, ending balance (in dollars per share) $ 24.78  
Aggregate Intrinsic Value (in thousands) $ 800,407 $ 757,446
Unvested restricted stock    
Number of RSUs and PRSUs Outstanding    
Unvested, beginning balance (in shares) 54,977  
Vested (in shares) (54,977)  
Forfeited (in shares) 0  
Unvested, ending balance (in shares) 0  
Weighted-Average Grant Date Fair Value    
Unvested, beginning balance (in dollars per share) $ 20.02  
Vested (in dollars per share) 20.02  
Forfeited (in dollars per share) 0  
Unvested, ending balance (in dollars per share) $ 0  
Aggregate Intrinsic Value (in thousands) $ 0 $ 1,450
v3.23.1
Equity Incentive Plans - Summary of Stock-Based Compensation Expenses (Details) - USD ($)
$ in Thousands
12 Months Ended
Feb. 05, 2023
Feb. 06, 2022
Jan. 31, 2021
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Total stock-based compensation expense $ 327,617 $ 286,963 $ 242,344
Cost of revenue—product      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Total stock-based compensation expense 10,245 6,334 4,001
Cost of revenue—subscription services      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Total stock-based compensation expense 22,630 21,240 14,979
Research and development      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Total stock-based compensation expense 161,694 142,264 117,220
Sales and marketing      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Total stock-based compensation expense 72,507 71,439 65,248
General and administrative      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Total stock-based compensation expense $ 60,541 $ 45,686 $ 40,896
v3.23.1
Net Income (Loss) per Share Attributable to Common Stockholders - Net Income (Loss) per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Feb. 05, 2023
Feb. 06, 2022
Jan. 31, 2021
Earnings Per Share [Abstract]      
Net income (loss) attributable to common stockholders, basic $ 73,071 $ (143,259) $ (282,076)
Add: Interest charges related to our Notes 3,314 0 0
Net income (loss) attributable to common stockholders, diluted $ 76,385 $ (143,259) $ (282,076)
Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, basic (in shares) 299,478 285,882 267,824
Add: Dilutive effect of common stock equivalents (in shares) 39,706 0 0
Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, diluted (in shares) 339,184 285,882 267,824
Net income (loss) per share attributable to common stockholders, basic (in dollars per share) $ 0.24 $ (0.50) $ (1.05)
Net income (loss) per share attributable to common stockholders, diluted (in dollars per share) $ 0.23 $ (0.50) $ (1.05)
v3.23.1
Net Income (Loss) per Share Attributable to Common Stockholders - Shares Excluded (Details) - shares
shares in Thousands
12 Months Ended
Feb. 05, 2023
Feb. 06, 2022
Jan. 31, 2021
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]      
Anti-dilutive securities excluded from computation of earnings per share, amount (in shares) 41,187 72,440 80,337
Stock options to purchase common stock      
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]      
Anti-dilutive securities excluded from computation of earnings per share, amount (in shares) 10,516 15,686 23,180
Unvested RSUs and PRSUs      
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]      
Anti-dilutive securities excluded from computation of earnings per share, amount (in shares) 29,780 32,491 31,980
Unvested restricted stock      
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]      
Anti-dilutive securities excluded from computation of earnings per share, amount (in shares) 6 257 1,145
Shares related to convertible senior notes      
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]      
Anti-dilutive securities excluded from computation of earnings per share, amount (in shares) 0 21,884 21,884
Shares issuable pursuant to the ESPP      
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]      
Anti-dilutive securities excluded from computation of earnings per share, amount (in shares) 885 2,122 2,148
v3.23.1
Other Income (Expense), Net (Details) - USD ($)
$ in Thousands
12 Months Ended
Feb. 05, 2023
Feb. 06, 2022
Jan. 31, 2021
Other Income and Expenses [Abstract]      
Interest income $ 17,320 $ 9,371 $ 17,442
Interest expense (4,749) (36,677) (31,403)
Foreign currency transactions gains (losses) (8,345) (5,235) 2,507
Other income 4,069 2,443 2,327
Total other income (expense), net $ 8,295 $ (30,098) $ (9,127)
v3.23.1
Income Taxes - Schedule of Geographical Breakdown of Income (Loss) before Provision for Income Taxes (Details) - USD ($)
$ in Thousands
12 Months Ended
Feb. 05, 2023
Feb. 06, 2022
Jan. 31, 2021
Income Tax Disclosure [Abstract]      
Domestic $ 39,004 $ (192,058) $ (312,119)
International 52,804 63,562 41,959
Income (loss) before provision for income taxes $ 91,808 $ (128,496) $ (270,160)
v3.23.1
Income Taxes - Components of Provision for Income Taxes (Details) - USD ($)
$ in Thousands
12 Months Ended
Feb. 05, 2023
Feb. 06, 2022
Jan. 31, 2021
Current:      
State $ 5,999 $ 592 $ 442
Foreign 12,020 12,525 8,006
Total 18,019 13,117 8,448
Deferred:      
Federal (639) 0 (218)
State (99) 0 0
Foreign 1,456 1,646 3,686
Total 718 1,646 3,468
Provision for income taxes $ 18,737 $ 14,763 $ 11,916
v3.23.1
Income Taxes - Reconciliation of the Federal Statutory Income Tax Rate and Effective Income Tax Rate (Details) - USD ($)
$ in Thousands
12 Months Ended
Feb. 05, 2023
Feb. 06, 2022
Jan. 31, 2021
Income Tax Disclosure [Abstract]      
Tax at federal statutory rate $ 19,280 $ (26,984) $ (56,734)
State tax, net of federal benefit 4,625 468 349
Stock-based compensation expense (11,976) (19,658) (604)
Research and development tax credits (26,634) (16,783) (14,138)
U.S. taxes on foreign income 19,065 25,059 14,021
Foreign rate differential (425) (1,698) 2,282
Withholding tax 2,339 143 34
Change in valuation allowance 10,631 48,270 63,146
Non-deductible expenses 2,091 4,381 0
Other (259) 1,565 3,560
Provision for income taxes $ 18,737 $ 14,763 $ 11,916
v3.23.1
Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Feb. 05, 2023
Feb. 06, 2022
Deferred tax assets:    
Net operating loss carryforwards $ 198,495 $ 369,904
Tax credit carryover 171,775 134,085
Accruals and reserves 34,506 22,625
Deferred revenue 87,026 66,242
Stock-based compensation expense 25,564 25,247
ASC 842 lease liabilities 40,772 28,577
Capitalized research and development 154,027 0
Other 4,950 1,879
Total deferred tax assets 717,115 648,559
Valuation allowance (598,997) (554,553)
Total deferred tax assets, net of valuation allowance 118,118 94,006
Deferred tax liabilities:    
Depreciation and amortization (31,744) (12,992)
Deferred commissions (53,421) (53,219)
Convertible debt 0 (4,642)
ASC 842 right-of-use assets (36,366) (24,608)
Acquired intangibles and goodwill (4,702) (6,850)
Interest income (2,521) (874)
Total deferred tax liabilities (128,754) (103,185)
Net deferred tax liabilities $ (10,636) $ (9,179)
v3.23.1
Income Taxes - Additional Information (Details) - USD ($)
12 Months Ended
Feb. 05, 2023
Feb. 06, 2022
Jan. 31, 2021
Feb. 02, 2020
Operating Loss Carryforwards [Line Items]        
Undistributed earnings of foreign subsidiaries $ 176,200,000      
Deferred tax assets, increase (decrease) in valuation allowance 44,400,000 $ 70,100,000    
Gross unrecognized tax benefit 68,897,000 $ 51,582,000 $ 39,571,000 $ 28,570,000
Unrecognized tax benefits that would impact effective tax rate 6,200,000      
Current or cumulative interest and penalties related to uncertain tax positions 0      
Federal        
Operating Loss Carryforwards [Line Items]        
Net operating loss carryforwards 795,100,000      
Research and development tax credit carryforwards 134,200,000      
State        
Operating Loss Carryforwards [Line Items]        
Net operating loss carryforwards 578,000,000      
Research and development tax credit carryforwards $ 116,000,000      
v3.23.1
Income Taxes - Activity Related to Unrecognized Tax Benefits (Details) - USD ($)
$ in Thousands
12 Months Ended
Feb. 05, 2023
Feb. 06, 2022
Jan. 31, 2021
Reconciliation of Unrecognized Tax Benefits      
Gross unrecognized tax benefits—beginning balance $ 51,582 $ 39,571 $ 28,570
Decreases related to tax positions taken during prior years 0 (173) (345)
Increases related to tax positions taken during prior years 2,172 1,201 1,881
Increases related to tax positions taken during current year 15,143 10,983 9,465
Gross unrecognized tax benefits—ending balance $ 68,897 $ 51,582 $ 39,571
v3.23.1
Segment Information - Revenue by Geographic Area (Details) - USD ($)
$ in Thousands
12 Months Ended
Feb. 05, 2023
Feb. 06, 2022
Jan. 31, 2021
Revenues From External Customers And Long Lived Assets [Line Items]      
Total revenue $ 2,753,434 $ 2,180,848 $ 1,684,179
United States      
Revenues From External Customers And Long Lived Assets [Line Items]      
Total revenue 1,971,757 1,580,022 1,195,428
Rest of the world      
Revenues From External Customers And Long Lived Assets [Line Items]      
Total revenue $ 781,677 $ 600,826 $ 488,751
v3.23.1
Segment Information - Long-Lived Assets by Geographic Area (Details) - USD ($)
$ in Thousands
Feb. 05, 2023
Feb. 06, 2022
Revenues From External Customers And Long Lived Assets [Line Items]    
Property and equipment, net $ 272,445 $ 195,282
United States    
Revenues From External Customers And Long Lived Assets [Line Items]    
Property and equipment, net 259,131 187,228
Rest of the world    
Revenues From External Customers And Long Lived Assets [Line Items]    
Property and equipment, net $ 13,314 $ 8,054
v3.23.1
401(k) Plan - Additional Information (Details) - USD ($)
12 Months Ended
Feb. 05, 2023
Feb. 06, 2022
Jan. 31, 2021
Compensation Related Costs [Abstract]      
Maximum annual contributions per employee (as a percent) 85.00%    
Company match of employee contributions (percent) 50.00%    
Maximum annual employer contribution, per employee $ 4,000    
Company contributions to the plan $ 12,200,000 $ 11,100,000 $ 10,200,000